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Abstract 
 
Effects of Localized EphB2 Stimuation on Dendritic Filopodia of 
Hippocmampal Neurons 
 
Clifford Locke, Ph.D. 
 
University of Connecticut, 2018 
 
 
 
 
 
 
Dendritic filopodia are thin, dynamic protrusions of developing neurons that are 
thought to search the area surrounding dendrites for pre-synaptic axons.  Upon contact 
with axons, they are believed to transform into the mature glutamatergic post-synaptic 
compartments known as dendritic spines.  Through synaptic plasticity, dendritic spines 
are suggested to play crucial roles in learning and memory formation.  While 
glutamatergic activity is a major stimulus of dendritic spine formation, cell-cell 
recognition receptors also play significant roles.  
Eph receptors are receptor tyrosine kinases that act as cell-cell contact receptors 
through binding their membrane-bound ephrin ligands.  They are classified into EphA 
and EphB subtypes based on their preferential binding to either ephrinA or ephrinB 
ligands. EphB1, EphB2, and EphB3 are collectively necessary for dendritic spine 
formation in vivo.  They are thought to be activated at axo-dendritic contacts and trigger 
direct changes in actin polymerization that drive the transition from filopodia to spines.  
While the relevant signaling pathways have been extensively studied, how EphB 
Clifford Locke – University of Connecticut, 2018 
signaling changes the motility and morphology of dendritic filopodia to form dendritic 
spines remains poorly understood. 
To facilitate real-time monitoring of dendritic filopodia following EphB 
stimulation, a photoactivatable EphB2, optoEphB2, was developed.  Since Eph receptor 
clustering is necessary for efficient downstream signaling, optoEphB2 employs the blue 
light-induced clustering of Cryptochrome 2.  Photoactivation of optoEphB2 resulted in 
rapid tyrosine phosphorylation and signaling to SH2 domain proteins that are known to 
act downstream of EphB2.  In fibroblasts and hippocampal growth cones, optoEphB2 
activation resulted in collapse of protrusive structures, consistent with previous findings 
for EphB signaling.   
Surprisingly, localized activation of EphB2 at dendritic filopodia promoted 
filopodia branching and plasma membrane expansion. Activation along the dendritic 
shaft led to formation of new filopodial protrusions in an Arg- and Arp2/3-dependent 
manner.  In addition, local phosphatidylinositol(3,4,5)-triphosphate (PIP3) accumulation 
via phosphoinositide 3-kinase (PI3K) activation was necessary for protrusion formation 
and marked a key difference between dendrites and fibroblasts.  These results provided 
new insights into the role of EphBs in dendritic filopodia, suggesting that they may 
increase filopodia density near sites of axo-dendritic contact.  Differential regulation of 
PIP3 synthesis may represent an important underlying mechanism of the cell context-
dependence that characterizes Eph receptor signaling.  
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CHAPTER I: Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Attribution:  This chapter was proof-read by Ji Yu and Yi Wu.  Clifford Locke wrote the 
text, made the figures, and performed the experiments. 
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Motivation 
 
Dendritic spines are the mushroom-shaped protrusions of neuronal dendrites that 
comprise most post-synaptic terminals of excitatory synapses in the central nervous 
system (CNS).  Dendritic spines are supported by an actin cytoskeleton and contain a 
bulbous head that is connected to the dendritic shaft by a thin neck.  This architecture 
allows for the compartmentalization of post-synaptic proteins and electrical activity1,2.  
Dendritic spines are believed to play important roles in learning and memory formation 
in humans, and their numbers and morphology are tightly regulated throughout 
development.  Defects in dendritic spine formation, resulting in abnormal spine density or 
morphology, have been described in a number of developmental disorders3.   
Many studies have suggested that dendritic spines derive from thin, dynamic 
protrusions known as dendritic filopodia1,4.  The first study to suggest this model 
examined dendritic filopodia in cultured hippocampal neurons.  It was demonstrated that 
dynamic filopodia formed stable contacts with axons and that, following the first week in 
vitro, the density of dendritic filopodia decreased while that of dendritic spines 
increased4.  Later electron microscopy studies of rat hippocampal slices showed synaptic 
vesicles, which contain neurotransmitters, near sites of contact between filopodia and 
axons5.  It is thus thought that dendritic filopodia are dynamic protrusions that seek out 
axons, stabilize upon contact with them, and subsequently develop into post-synaptic 
dendritic spines.  Dendritic spines may then undergo maturation and strengthening, 
marked by growth of the spine head, or may be lost.  This dynamic nature is termed 
synaptic plasticity, while loss is often referred to as synaptic pruning, and these processes 
are thought to contribute to memory formation or loss6.  
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Changes in the actin cytoskeleton drive most aspects of dendritic spine formation 
from dendritic filopodia and subsequent plasticity7.  Changing the architecture of actin is 
necessary to form and enlarge the spine head and organize post-synaptic proteins, such as 
neurotransmitter receptors and important scaffolds.  Signaling pathways that ultimately 
converge on the actin cytoskeleton in these contexts are known to originate from the 
actions of glutamate, the major excitatory neurotransmitter in the CNS. Glutamate binds 
post-synaptic ionotropic receptors, triggering an influx of extracellular calcium.  
Calcium-sensitive proteins may then transmit signals to the cytoskeleton.  Generally, the 
result of repeated glutamatergic stimulation is spine head enlargement and recruitment of 
additional glutamate receptors, which strengthens the synapse6.   
While glutamate is the primary director of dendritic spine maturation, filopodia 
have been shown to form stable contacts with axons in the absence of glutamatergic 
activity8.  There is, therefore, a major role for cell-cell recognition molecules in the 
formation of dendritic spines9. An important family of cell-cell contact receptors that 
drive the formation of dendritic spines is the Eph receptor family.  Briefly, Eph receptors 
are members of the largest receptor tyrosine kinase (RTK) family in mammals, and are 
sub-classified into EphA (EphA1-A8, A10) and EphB (EphB1-B4, B6) subtypes. They 
become activated at cell-cell contacts upon binding their membrane-bound ligands, the 
ephrins, and subsequent receptor clustering10,11.  Their primary function is to guide 
migrating cells during developmental processes, and they therefore play important roles 
in gastrulation, cell positioning, tissue patterning, and organogenesis.   
Prior studies have suggested that EphB signaling promotes the formation of 
dendritic spines in hippocampal neurons12.  These conclusions were drawn from an initial 
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observation that overexpression of kinase-dead EphB2 in cultured rat hippocampal 
neurons impaired dendritic spine development13.  Follow-up work examined the 
morphology of dendritic protrusions in cultured mouse hippocampal neurons and brain 
slices when various combinations of EphB1, EphB2, and EphB3 were genetically 
knocked out.  It was found that knocking out two of these three EphB subtypes 
significantly reduced dendritic spine density in vitro, and knocking out all three of 
EphB1-B3 reduced spine density in vivo14.  Additionally, many studies used ephrinB 
ligands to stimulate EphB signaling in cultured hippocampal neurons and observed 
increased dendritic spine density and spine head size15.  These studies strongly suggested 
that signaling from EphB receptors was necessary for both proper spine formation and 
maturation, and that EphB1-B3 were at least partially redundant in these processes. 
To understand the effect of EphB signaling on dendritic spine formation, a logical 
step is to understand how they affect dendritic spine precursor structures, dendritic 
filopodia.  Indeed, by knocking down EphB2 in cultured hippocampal neurons in a time-
specific fashion, it was found that the effect of EphB2 on spine formation was confined to 
the second week in vitro, when filopodia are most abundant16.  Overexpression of EphB2 
rescued dendritic spine loss in EphB1-B3 triple-knockout neurons only during this time 
frame as well16.  This suggested that EphB signaling must have specific effects on 
dendritic filopodia that promote their transition to dendritic spines.  
Interestingly, neurons cultured from EphB1-EphB3 triple-knockout mice 
displayed normal filopodia density early in development16, suggesting that EphB 
signaling did not affect filopodia formation.  However, decreased filopodia motility was 
observed versus wild-type neurons16.  This would suggest that basal EphB activity is 
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important to maintain the motility of dendritic filopodia, a property that is important for 
their axon-searching function.  Other studies examined the effects of EphB signaling by 
stimulating cultured neurons with ephrinB ligands.  In addition to increasing spine 
formation, ligand stimulation also resulted in an overall increase in dendritic protrusion 
density, including spines and filopodia, and filopodia shortening14,17.  These outputs are 
consistent with a role for EphB signaling in increasing the number of dendritic spines.  
Filopodia shortening is expected during dendritic spine morphogenesis, immediately 
following contact formation, and increasing protrusion density would necessarily lead to 
more potential contact sites.  
The results discussed above are consistent with an increase in dendritic spine 
density following activation of EphB signaling by ephrinB binding, but do not fully 
address how this signaling contributes to the transition from filopodia to spines.  
Genetically knocking out EphB1-B3 eliminates their basal activities, but does not fully 
address how their signaling affects filopodia motility or morphology at axo-dendritic 
contacts, where EphBs are presumably engaged by their ligands.  Knocking out EphB 
isoforms may also affect the expression of other proteins, and the observed effects may 
have been the result of an abnormal pattern of protein expression.  Since ephrinB ligand 
treatment increased protrusion density, one may expect that EphB1-B3 triple-knockout 
would reduce protrusion density, though no effect was observed.  Protrusion density is 
inherently governed by both the rate of protrusion formation and loss.  It is unclear if the 
increased protrusion density was secondary to increased formation of filopodia, some of 
which may have become spines, or stabilization of existing protrusions.  Increased 
protrusion formation would not be supported by the separate finding of filopodia 
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shortening upon EphB stimulation; elongation would be expected to promote protrusion 
formation.  Additionally, bath application of ligands does not fully reflect what may 
happen to single filopodia when EphBs are activated at individual contacts.   
Therefore, the effects of EphB signaling on the motility and morphology of 
dendritic filopodia remain poorly understood.  This biological question is the primary 
motivation behind this thesis, and answering it will improve our understanding of how 
EphBs transform filopodia into spines.  A number of hypotheses can be made.  Since 
EphBs are activated at cell-cell contacts, and filopodia must stabilize upon contact with 
axons to become spines, EphB signaling may initiate spine morphogenesis by directing 
contact stabilization.  One would expect, then, reduced filopodia motility in response to 
EphB stimulation.  EphB signaling at contacts along the dendritic shaft is also possible, 
since EphBs are expressed on the dendritic shaft18.  EphBs may direct the formation of 
protrusions from the dendritic shaft, which may then become spines.  The known 
interactions between EphBs and glutamate receptors19,20 may suggest that EphBs have no 
direct effect on the actin cytoskeleton.  Rather, their function may be to recruit glutamate 
receptors to filopodia, whose activity via calcium influx  may then independently alter the 
actin cytoskeleton to direct the transition to mature dendritic spines.  
Observing the effect of EphB signaling on the morphology and motility of 
dendritic filopodia would be facilitated by spatial and temporal control over EphB 
signaling.  This would ensure that signaling originates from dendritic filopodia, which 
would better simulate the scenario of filopodia coming into contact with axons.  Thus, the 
aims of this thesis were two-pronged: to develop a technique to spatially and temporally 
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stimulate EphB signaling, and then dynamically monitor responses of dendritic filopodia 
to localized stimulation.   
This chapter provides a detailed overview of the topics covered in this thesis.  I 
will begin with a discussion of Ephs and ephrins, covering the structural and molecular 
basis behind their signaling and functional consequences.  A discussion of optogenetics 
and, specifically, the blue light-sensitive plant photoreceptor Cryptochrome 2 follows.  
Dendritic spine formation and the role of Eph receptors in this process will then be 
discussed.  I will then give a summary of experimental results and the primary 
conclusions of this thesis, which will be discussed in detail in Chapters II and III.  
 
Eph Receptors and Ephrins 
Erythropoietin-producing human hepatocellular carcinoma (Eph) receptors 
comprise the largest family of receptor tyrosine kinases (RTKs) in humans10.  As their 
name suggests, the first Eph receptors were identified in 1987 as candidate oncogenes in 
an erythropoietin-producing hepatocellular carcinoma cell line21.  Since then, nine EphA 
(EphA1-A8, A10) and five EphB (EphB1-B4, B6) receptors have been characterized in 
humans10.  This classification into A and B subtypes is based on the receptors’ relative 
binding affinities for the five glycosyl phosphatidylinositol (GPI)-linked ephrinA 
(ephrinA1-A5) or three transmembrane ephrinB (ephrinB1-B3) ligands.  It should be 
noted, however, that these binding interactions display some promiscuity.  For instance, 
EphA4 binds ephrinBs, and ephrinA5 is capable of binding EphBs22,23.   
Both Ephs and ephrins are membrane-bound and are therefore activated at cell-
cell contacts.  Uniquely, both the receptors and ligands transmit downstream signals, 
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resulting in so-called “bidirectional” signaling24.  Colloquially, signaling from Eph 
receptors is termed “forward” signaling, and “reverse” signaling emanates from ephrins.  
Eph receptors and ephrins transduce cell-cell contacts into changes in cell migration, 
proliferation, and survival.  They are crucial to normal cell positioning and tissue 
patterning during developmental processes, such as organogenesis, tissue boundary 
formation, topographic mapping, axon guidance, and synaptogenesis10. As suggested by 
their discovery, Eph receptors are also important in cancer biology and are known to 
function as tumor suppressors and promoters, depending on the Eph receptor subtype and 
type of cancer24.   
The structure, function, and signaling pathways that define Eph receptors mirror 
those of other members of the RTK family.  To fully appreciate their biology, an 
overview of RTKs is given.  Specific features of Eph receptors will follow. 
 
Receptor Tyrosine Kinases 
 Receptor tyrosine kinases (RTKs) are unique transmembrane receptors that 
regulate critical cell functions, including cell proliferation, differentiation, migration, and 
survival25.  A large number of RTK families exist and many, for example, the fibroblast 
growth factor receptor (FGFR) and epidermal growth factor receptor (EGFR) families, 
respond to growth factors.  RTKs are crucial in developmental processes, and mutations 
or other dysfunctions of RTKs are associated with numerous developmental and 
neoplastic disease states.  For example, many breast cancers are marked by 
overexpression of the EGFR family member ErbB226, and Kallman Syndrome27, a 
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developmental disorder affecting the normal development of cranio-facial structures, is 
caused by a mutation in FGFR1.      
Typically, RTKs are composed of extracellular domains that consist of a ligand-
binding domain and other unique motifs, a transmembrane domain, and intracellular 
domains with catalytically-active tyrosine kinases27.  Most RTK intracellular domains 
assume an auto-inhibitory conformation in the inactive state. Typically, ligand-induced 
dimerization results in auto-phosphorylation events that relieve this auto-inhibitory 
configuration27. Intracellular tyrosine kinase domains may then access their substrates, 
which include tyrosine residues on the receptors themselves that are phosphorylated in 
trans and other downstream signaling molecules.   
Phosphotyrosines on the RTKs and their substrates serve as docking sites for 
proteins containing Src homology-2 (SH2) and phosphotyrosine binding (PTB) 
domains28.  The various SH2 and PTB domains selectively bind different 
phosphopeptides28–30, which allows many RTKs to display specificity for particular 
effectors.  These SH2/PTB domain-containing proteins may serve as adaptors or 
scaffolds to organize large macromolecular complexes, such as focal adhesions, and 
others contain enzymatic properties.  Some, such as Src, Abl, and Arg, are tyrosine 
kinases themselves, known as non-receptor tyrosine kinases (NRTKs)28.  Interactions 
other than SH2/PTB domain-phosphotyrosine interactions, such as PDZ (PSD-95, Discs 
large, Zona occludens-1) domain binding, Src homology-3 (SH3) domain binding to 
polyproline motifs, and plasma membrane lipid alterations, are also important in RTK 
signaling pathways.  In many cases, these occur as secondary interactions with SH2/PTB 
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domain proteins that stabilize phosphotyrosine-mediated interactions27.  These other 
interactions also diversify the signaling complexes formed by SH2 domain adaptors.  
Downstream signals from RTKs affect the cytoskeleton and expression of genes 
that regulate cell survival, metabolism, cell cycle progression, and differentiation31.  
Major downstream signaling pathways include the Rho family of GTPases, the 
Ras/MAPK signaling cascade, and phosphoinositide 3-kinase (PI3K) signaling.  Some 
receptors do not themselves contain tyrosine kinase activity, but resemble RTKs by 
associating with the Janus family of NRTKs (JAK), which activate the signal transducer 
and activator of transcription (STAT) family of transcription factors25.  The Rho and Ras 
GTPases and PI3K signaling are most relevant to this thesis and are discussed in further 
detail below. 
Rho and Ras GTPases are signaling proteins with intrinsic GTPase activity that 
are active when GTP-bound and inactive when GDP-bound.  Relevant to this discussion, 
the Rho GTPase family refers to the GTPases Rac1, Cdc42, and RhoA32.  The Ras 
GTPases consist of a variety of members, with emphasis here on the canonical H-Ras, N-
Ras, and K-Ras isoforms, collectively referred to as “Ras” in many publications, and the  
Ras-related (R-Ras) proteins33.  RTKs typically regulate their activity by signaling 
guanine nucleotide exchange factors (GEFs), which activate GTPases by facilitating 
replacement of GDP with GTP, and GTPase-activating proteins (GAPs), which inhibit 
GTPase signaling activities by facilitating hydrolysis of GTP to GDP27,31,32.   
Most canonical Ras isoforms signal the Raf family of kinases, which then activate 
the mitogen-activated protein kinase (MAPK) cascade.  This cascade is a string of 
kinases, beginning with activation of the Raf kinases, which then phosphorylate and 
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activate MAPK kinase (MEK), which then activates MAPK, also known as ERK.  
Phosphorylated ERK isoforms may translocate to the nucleus, where they increase the 
transcription of genes that promote cell growth and survival31.  Both canonical Ras and 
R-Ras proteins are capable of activating PI3K.  However, R-Ras proteins typically do not 
interact with Raf kinases and activate the MAPK cascade34.  In addition to gene 
regulation, canonical Ras and R-Ras family members can activate or inhibit signaling of 
integrins, which are transmembrane receptors that bind extracellular matrix (ECM) 
proteins to influence cell adhesion and migration35. 
The Rho GTPases Rac1, Cdc42, and RhoA affect cell migration and motility by 
altering actin polymerization32.  RhoA is generally thought to direct cell retraction by 
signaling through Rho-associated protein kinase (ROCK) to activate myosin-based 
contractile forces.  It may also signal the mDia family of formins, which increase actin 
polymerization.  Rac1 and Cdc42 signal WAVE and N-WASP, respectively, which may 
activate the Arp2/3 complex and nucleate branched actin filaments.  They also signal 
through p21-associated kinase (PAK) to inhibit acto-myosin contractile forces.  They, 
therefore, mediate the formation of cellular protrusions.  Lamellipodia are formed by 
inducing broad plasma membrane extensions through nucleation of a highly-branched 
actin network.  Filopodia are formed by elongating parallel actin bundles32.  Tight spatial 
and temporal regulation of these Rho GTPases are necessary for proper cell motility, 
migration, and polarity.    
Phosphoinositie-3-kinases (PI3K, Fig. 1.1) comprise a family of lipid kinases that 
phosphorylate the 3-hydroxyl group of inositol ring of phosphatidylinositol family lipids 
on the inner leaflet of the plasma membrane.  Of special interest in RTK signaling are the 
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class I PI3Ks, which are composed of regulatory and catalytic subunits.  Some regulatory 
subunits contain SH2 domains that bind phosphotyrosines on RTKs.  These subunits 
derive from three genes: p85, p55, and p50 are splice isoforms of the PIK3R1 gene, 
p85 is the product of the PIK3R2 gene, and p55 is the product of the PIK3R3 gene36.  
Each regulatory subunit contains two SH2 domains whose inter-SH2 domain binds the 
catalytic subunits p110, p110, and p110.  The regulatory subunits hold the catalytic 
subunits in an inactive conformation, and recruitment to phosphotyrosines in RTK 
signaling complexes is one mechanism to relieve this inhibition and bring the catalytic 
subunits to their plasma membrane substrates36.  In addition to regulatory subunit 
recruitment, Ras GTPases also activate class I PI3K activity through binding the catalytic 
subunit37–39.   
Class I PI3Ks phosphorylate the plasma membrane lipid 
phosphatidylinositol(4,5)-bisphosphate (PIP2) to form phosphatidylinositol(3,4,5)-
triphosphate (PIP3)
36.   These lipids serve crucial roles in regulating actin polymerization 
and gene expression.  PIP3 and, in some cases, PIP2, can interact with lipid-binding 
domains, such as the pleckstrin homology (PH) domain, in a variety of proteins to 
activate their signaling.  Notable examples include Akt/protein kinase B, many of the 
same adaptors that signal in RTK signaling complexes, and GEFs and GAPs that activate 
and inhibit Ras and Rho family GTPases36. Akt is a serine/threonine kinase that promotes 
cell survival.  Its signaling promotes the expression of anti-apoptotic proteins and 
degradation of pro-apoptotic proteins.  Akt also increases protein translation by signaling 
the mammalian target of rapamycin (mTOR)40.  The PH domains of many GEFs and 
GAPs have been shown to bind PIP3 and, in some cases, this binding enhances their 
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activation36.  Subsequent changes in Rho GTPase activity affect actin polymerization and 
cell migration32, as outlined previously.  
As previously stated, Eph receptors are very similar to other RTKs in their 
signaling activation and properties.  They do, however, display many unique features that 
allow them to serve specific functions, such as their role in contact repulsion secondary to 
their activation at cell-cell contacts.  Details are discussed for the remainder of this 
section. 
 
Structural Basis of Eph Receptor Clustering and Forward Signaling 
Like other RTKs, Eph receptors undergo autophosphorylation upon ligand 
binding and transmit downstream signals through tyrosine phosphorylation of substrates 
and binding other adaptors.  As previously discussed, Eph receptor ligands are 
membrane-bound and capable of transmitting downstream signals. Another unique 
feature of Eph receptors is the requirement of receptor clustering for efficient 
downstream signaling11 (Fig. 1.2).  This was first demonstrated by Davis et al.41, who 
showed that only membrane-bound or antibody-clustered ephrin ligands were sufficient 
to activate Eph receptors.  Another study showed that dimerized soluble ligands were 
sufficient to induce Eph receptor autophosphorylation, but larger aggregates were 
necessary for downstream effector recruitment and to observe expected changes in cell 
adhesion and migration42.  Studies that examined the effect of cluster size, by either 
antibody-mediated soluble ligand clustering42 or chemical cross-linking43, demonstrated 
that Eph receptor aggregates larger than dimers represent the minimum signaling unit 
required for Eph receptor signaling.  It was also suggested larger clusters transmit 
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stronger signals43. Studies have shown that different types of Eph receptors, including 
both EphAs and EphBs, may co-exist in the same cluster, and signaling outputs depend 
on the relative amounts of each receptor present11,44.  Signaling pathways and functional 
consequences downstream of Eph receptor signaling are, thus, highly complex.  The 
structural basis of ligand-receptor binding, Eph receptor activation, and clustering have 
been analyzed by a variety of structural studies.   
This section will focus primarily on forward signaling, but a brief overview of 
ephrin reverse signaling is provided here.  Both ephrinBs and ephrinAs consist of 
extracellular receptor-binding domains (RBDs, Fig. 1.2) and bind Ephs with high affinity.  
A surface plasmon resonance study showed that single ephrin-Eph interactions bind with 
a dissociation constant on the order of tens of nM45.  EphrinBs are transmembrane 
proteins with unstructured intracellular domains that contain C-terminal PDZ binding 
motifs and numerous conserved tyrosine residues that are phosphorylated upon activation 
(Fig. 1.2).  It is thought that tyrosine phosphorylation of ephrinBs is carried out by other 
tyrosine kinases, especially the Src family46.  EphrinBs serve many of the same functions 
as Eph receptors through binding SH2 domain adaptors, such as Grb4, and PDZ domain 
proteins47. EphrinAs are GPI-linked and entirely extracellular.  They associate with co-
receptors to transmit downstream signals.  For instance, ephrinAs are known to bind and 
signal through the neurotrophin receptor p75 in retinal axons to direct growth cone 
steering during axon guidance48.          
The general structure of Eph receptors is shown in Figure 1.2.  In the extracellular 
region, EphA and EphB receptors contain an N-terminal ligand-binding domain (LBD), 
followed by a cysteine-rich domain (CRD) that contains sushi and EGF-like motifs, and 
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two fibronectin-type III repeats10.  The juxtamembrane (JM) region immediately C-
terminal to the transmembrane domain contains conserved phosphotyrosine motifs that 
relieve intracellular autoinhibition of the kinase domain upon phosphorylation49.  They 
are also major binding sites for SH2 domain-containing proteins, though many sites have 
been identified throughout the intracellular domain50–53.  The JM region is followed by 
the kinase domain, and the C-terminus of Eph receptors consists of a sterile-alpha motif 
(SAM) and a PDZ-binding motif (PBM).  
Eph-ephrin signaling is believed to initiate from heterotetramers consisting of two 
ephrins and two Ephs.  The structure of these heterotetramers was determined by X-ray 
crystallography of purified complexes containing the ephrinB2 ECD and the EphB2 
LBD54.  The heterotetramers were formed by multivalent interactions that allowed each 
ephrin to simultaneously bind both Eph receptors, and vice versa, through two interfaces 
in the Eph LBD and ephrin ECD.  One of these interfaces was, of course, composed of 
the Eph receptor ligand-binding pocket and the ephrin receptor binding domain, and the 
other was located outside of these regions.  Other structural studies observed similar 
interactions55,56.  It is thought that these heterotetramers then arrange into higher-order 
clusters.  Further crystallography studies with larger portions of the Eph receptors’ ECDs 
predicted residues in the CRD and LBD that mediate cis interactions between receptors 
on the same cell surface55,56.  Thus, Ephs may initially bind ephrins in the heterotetramer 
arrangement and then use the CRD- and LBD-mediated interactions to expand into 
clusters. 
Interestingly, the LBD- and CRD-mediated receptor-receptor interactions were 
observed in the absence of ligand binding.  Overexpression of Eph receptors induced 
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ligand-independent receptor autophosphorylation that was abrogated by select point 
mutations in the CRD56.  These results suggested that clustering is an intrinsic property of 
the receptors themselves and may only depend on the concentration of receptors on the 
cell surface.  It is possible that ephrin ligands only serve to increase the local 
concentration of receptors, or orient the receptors in an appropriate conformation, to 
promote clustering.  This idea is supported by the observation that the Eph receptor ECD 
undergoes little conformational change after ligand binding56. Additionally, 
immunofluorescence studies have shown that ephrins may exist in plasma membrane 
microdomains, and some studies suggest that ephrins associate with lipid rafts57,58.  These 
results suggest that ephrins are closely-packed to begin with.  In fact, ephrin receptor-
binding domains have been shown to homo-dimerize54.  Since Eph receptors can self-
associate, it is also possible that both ephrins and Eph receptors exist in an equilibrium 
between monomers and dimers, and that ephrin dimers can cross-link Eph receptor 
dimers to result in clustering arrays. 
Other domains of Eph receptors, and their effectors, have been shown to modulate 
Eph receptor clustering.  The N-terminal fibronectin type III (FNIII) repeat was shown to 
contain a receptor-receptor binding interface in EphAs55.  Crystal structures of the SAM 
domain showed the potential for dimerization59, suggesting a role for intracellular 
regulation of Eph receptor dimerization or clustering.  Additionally, studies suggest that 
interactions between Eph receptors and PDZ domain proteins may promote or reduce Eph 
receptor clustering and activation.  Overexpression of the PDZ domain protein PICK1 
with EphB2 in COS7 cells induced EphB2 clustering60.  However, deletion of the SAM 
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and PBM of EphB2 was independently shown to enhance EphB2 clustering and 
activation43. 
Eph receptor clustering results in complex functional consequences.  Ephs of 
different types, including those of different classes, may co-exist in the same signaling 
complexes.  This was demonstrated by co-immunoprecipitation of, and co-localization of 
clusters containing, EphB2 and EphA3 receptors in HEK293 cells44.  Treatment with 
ephrinA or ephrinB ligands caused phosphorylation of both EphB2 and EphA3, 
suggesting cross-phosphorylation44.  Some data suggest that ephrin stimulation of cells 
often results in functional outputs that represent a composite of all Eph receptors 
expressed, and are dependent on the relative expression level of each receptor subtype11.  
Competition between Eph receptors on the same cell has been shown.  Astin et al. 
(2010)61 used ephrinA5- and ephrinB2-coated microbeads to stimulate Eph signaling in a 
prostate cancer cell line.  While ephrinA5 caused cell repulsion, ephrinB2 promoted cell 
migration, and was able to reverse cell repulsion caused by ephrinA5 when both ligands 
were present on the same beads61.   
Given the promiscuity of ligand binding and the heterogeneity of Eph receptor 
clusters, canonical signaling pathways for each receptor subtype remain elusive10.  
Adding to this complexity is the cell context-dependence of Eph receptor signaling.  An 
individual Eph receptor subtype may trigger diametrically-opposed responses in different 
cell types, and the mechanism behind this phenomenon is poorly understood.  The 
following section will outline the regulation, major downstream pathways, and functional 
consequences of Eph receptor signaling.  
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Functions and Mechanisms of Eph Receptor Signaling 
Eph receptors signal the actin cytoskeleton and affect protein expression to 
regulate cell adhesion, migration, and survival.  Eph-ephrin signaling cascades typically 
mediate repulsive cues, and spatial gradients of Eph and ephrin expression across tissues 
are regulated over space and time to ensure that cells or cellular processes migrate to the 
right place at the right time10.  This interplay between repulsive cues and spatial 
regulation has been well-studied in topographic mapping of the central nervous system by 
Eph receptor-mediated axon guidance62–64.  EphA-expressing growth cones in the 
retinotectal system, for example, were shown to be directed from areas of high ephrinA 
expression to areas of low expression.  This process ensures that axons from a given 
visual field in the retina reach their appropriate target neurons in the superior colliculus64.  
As another example, Eph/ephrin signaling is important to establish boundaries between 
arterial and venous vascular structures65.   
Eph and ephrin signaling outputs are highly heterogeneous and cell context-
dependent, and Eph receptor signaling sometimes functions to promote cell migration and 
cell-cell adhesion.  For example, EphB4 promotes tumor growth in some breast and lung 
cancers66,67, but was shown to have tumor-suppressing effects in colorectal cancer68.  
EphrinA1/EphA2 forward signaling is pro-angiogenic by increasing endothelial cell 
migration69, but inhibits the migration of prostate cancer and glioma cells70.  The cause of 
this cell context-dependence is unclear.  Some studies of Eph receptor signaling to 
specific downstream effectors have addressed this question, and will be discussed below.  
 Functional consequences of Eph receptor signaling  are primarily mediated by the 
Rho GTPases Rac1, Cdc42, and RhoA, the Ras family of GTPases, and PI3K10. The 
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following sections will focus on how Eph/ephrin forward signaling affects the 
aforementioned pathways to confer cell-cell repulsion or adhesion, and cell survival or 
death, with illustrative examples.  The nature of cell context-dependence will be 
discussed where appropriate.  I will focus on EphB signaling pathways as illustrative 
examples over EphAs due to the nature of my thesis work.  
 
Ras Family GTPases 
Unlike many other RTKs, Eph receptors have been shown to induce cell process 
retraction and reduce cell adhesion and survival by inhibiting R-Ras and Ras/MAPK 
signaling47.  In general, published literature on this topic does not differentiate between 
the canonical Ras isoforms H-Ras, K-Ras, and N-Ras, and, as such, the connotation 
“Ras” will indicate the canonical isoforms collectively and the term “R-Ras” will refer 
specifically to the R-Ras proteins.  A common mechanism among Eph receptors to inhibit 
Ras and R-Ras is activation of p120RasGAP through binding its SH2 domain47,71,72.  
EphB2 induced repulsive responses in COS-1 cells and neurite retraction in EphB2-
expressing neuroblastoma (NG-108) cells by activating p120RasGAP50,71,72.  Since the 
Ras/MAPK pathway acts downstream of many RTKs, Eph receptor signaling can 
modulate outputs from other RTKs.  For example,  Eph receptor signaling was shown to 
inhibit MAPK activation by the platelet-derived growth factor receptor (PDGFR) and the 
vascular endothelial growth factor receptor  (VEGFR), among others73.      
EphB2 has also been shown to reduce cell adhesion by inhibiting R-Ras through 
p120RasGAP or direct tyrosine phosphorylation72,74.  Inhibition of R-Ras by EphB2 was 
shown to reduce adhesion of cells to substrates containing integrin ligands74, suggesting 
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R-Ras inhibition as a means for Eph receptors to inhibit integrin-mediated adhesion.  This 
aspect of EphB2/R-Ras signaling may be relevant to cancer biology.  A study of glioma 
cell migration revealed that EphB2-mediated R-Ras tyrosine phosphorylation was 
associated with reduced adhesion and increased invasion75.  This study, however, 
characterized R-Ras tyrosine phosphorylation as activating, though there was no data to 
show an increase in GTP-bound R-Ras.  
In some contexts, Eph receptors may activate Ras/MAPK signaling.  Both EphA2 
and EphB1 increased MAPK signaling through binding the SH2 domain adaptor Grb2 
and members of the Shc family of SH2 domain adaptors, albeit with different functional 
outputs- EphA2-mediated signaling decreased ECM attachments, while EphB1 signaling 
promoted chemotaxis.  In both cases, MAPK activation and Grb2 recruitment were 
dependent on engaging Shc-family adaptors76,77.  Grb2 is known to associate with the 
Ras-GEF SOS, and presumably this mechanism is responsible for MAPK activation76.   
Some studies have explored the mechanism underlying this cell context-
dependence.  Signaling from other RTKs may influence the effect of Eph receptors on 
Ras.  For example, increased FGFR signaling was shown to switch the effect of EphB2 
from activation to inhibition of MAPK signaling78.  Differences in downstream effectors 
have also been suggested to play a role.  For example, a study of EphB4 signaling in 
human umbilical vein endothelial cells found that EphB4 inhibited Ras/MAPK signaling 
by engaging p120RasGAP.  However, EphB4 increased Ras activity in MCF7 breast 
cancer cells in a manner that depended on  protein phosphatase 2 (PP2A)79.  The 
respective effects on Ras activity were abrogated by knocking down p120RasGAP or 
PP2A.      
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Eph receptors may also activate or inhibit the Ras-related GTPase Rap1 in a cell 
context-dependent manner.  Briefly, Rap1 signaling overlaps with the other Ras 
superfamily GTPases, but is uniquely involved in regulating cell-cell junctions, largely 
through its effector, afadin80.  In fact, afadin can bind Eph receptors as well81.  Eph 
receptors typically activate Rap through the GEF C3G, which associates with the SH2 
adaptors Crk and CrkL10,82.  EphB signaling was shown to activate Rap through direct 
recruitment of Crk to increase membrane ruffling and cell adhesions in endothelial 
cells83.  In some contexts, however, Crk and CrkII are inhibited by recruitment of the 
NRTK Abl to Eph receptors, which deactivates Crk by phosphorylation and disrupts its 
effector binding67,82.  In neurons, EphA4 inhibits Rap through PBM-mediated recruitment 
of the Rap-GAP SPAR84. 
 
Rho Family GTPases 
Eph receptors may also initiate cell-cell repulsion by activation of RhoA and 
inhibition of Rac1 and Cdc42, resulting in acto-myosin contractility to inhibit protrusive 
structures and cell migration73,85.  EphAs are known to induce growth cone collapse, alter 
vascular smooth muscle contractility, and reduce T cell chemotaxis by activating RhoA 
through the ephexin family of RhoGEFs86,87.  In growth cone collapse, transient Rac1 
inhibition is accomplished through recruitment of the Rac1 GAP 2-chimaerin through 
binding its SH2 domain88.  Both ephexin and 2-chimaerin are tyrosine phosphorylated 
by the Src family kinases in this context88,89.  However, growth cone collapse requires 
Rac1 activity to endocytose the Eph/ephrin complexes, and recruitment of the GEF Vav2 
to EphA4 was suggested to play a role90.  EphBs are also known to activate RhoA to 
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induce growth cone collapse91,92, synaptogenesis17, and increase migration of invasive 
melanoma cells93,  though the specific GEFs involved are unknown.   
Eph receptors are also known to promote cellular protrusions and cell migration 
by favoring Rac1/Cdc42 signaling over RhoA in some contexts.  In addition to mediating 
endocytosis during growth cone collapse, Vav-mediated Rac1 activation is also important 
to induce endothelial cell migration in EphA-dependent angiogenesis94.  Another study 
showed PI3K upstream of Rac1 in this process, and Cdc42 activation was observed as 
well69. In glioma cells, EphA4 overexpression was associated with increased migration 
and proliferation due to Rac1 and Cdc42 activation95, though EphA4 showed interactions 
with FGFR in this context, and the effects may have been indirect.  EphB signaling 
increased membrane ruffling and cell adhesions in endothelial cells  by activating Rac1 
via the GEF DOCK1 downstream of Crk83.  EphBs, as discussed in a later section, also 
interact with the Rac-GEFs kalirin-7 and Tiam1 and the Cdc42-GEF intersectin to 
promote dendritic spine formation in hippocampal neurons12.  An interaction between 
EphB2 and the Rac-GEF -Pix96, mediated by the adaptor protein Nck, has been 
demonstrated and also suggests Rac1 and Cdc42 activation by EphBs. In prostate cancer 
cells, EphAs and EphBs were shown to differentially regulate contact inhibition of 
locomotion through selective Rho GTPase activation61.  EphAs induced cell process 
retraction through RhoA, and EphBs increased cell migration through Cdc42. 
 
Phosphoinositide 3-kinase 
Eph receptors also display highly context-dependent regulation of class I PI3K 
activity to promote or suppress cell survival and migration.  The general functions of Eph 
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receptors to mediate repulsive cues and inhibit Ras are consistent with inhibition of PI3K 
signaling.  EphB2, for example, was shown to inhibit PI3K signaling pathways in 
multiple contexts.  EphrinB1 stimulation of EphB2 and EphB4 in medulloblastoma cells 
decreased cell adhesion and levels of phosphorylated mTOR97, indicating reduced 
PI3K/Akt signaling.  A recent study of chemotaxis in MTLn3 breast cancer cells 
overexpressing EGFR showed down-regulation of PI3K activity by EphB2 that opposed 
EGFR-mediated chemotaxis98.  However, EphB signaling is known to activate PI3K in 
other contexts.  Intrathecal and peripheral injections of ephrinB1-Fc in living mice 
induced hyperalgesia that was dependent on increased expression and activity of PI3K 
catalytic subunits99,100. EphB2-mediated activation of -Pix through PI3K was 
demonstrated in 293T cells96.  Additionally, EphB2 was shown to inhibit Tau 
phosphorylation, which promotes the pathogenesis of Alzheimer’s Disease, in mature 
hippocampal neurons by activating PI3K signaling101.   
Little is known about how PI3K is activated or inhibited downstream of EphBs.  
Inhibition may be mediated by inhibition of Ras family GTPases, which are known PI3K 
activators37.  Activation may occur through recruitment of regulatory subunits, suggested 
by an in vitro interaction reported between phosphorylated EphB2 and the SH2 domain 
of p85 ( or  not specified)50.  A study of EphB2 signaling in colonic crypt cells in vivo 
showed that EphB2 promotes PI3K-dependent cell migration in an EphB2 kinase-
independent manner102.  Kinase-independent signaling would suggest a mechanism 
independent of SH2 binding and, perhaps, constitutive association with a PI3K activator.  
Other Eph receptors present a similarly complex story.  EphA2, for example, was 
shown to promote vascular endothelial cell migration through PI3K following ephrinA1 
  24 
stimulation69.  Similar treatment of glioma and prostate cancer cells, however, caused 
reduced cell migration secondary to PI3K inhibition70.  In the same study, overexpression 
of EphA2 was shown to increase migration in these cells in a ligand-independent manner, 
suggesting PI3K activation in the absence of kinase activity70.  These results are 
strikingly similar to the aforementioned observations of kinase-independent PI3K 
activation by EphB2 in colonic crypts102, raising the possibility of a common mechanism.  
However, PI3K activation is largely thought to occur by regulatory subunit recruitment or 
Ras activation, both of which typically require RTK activation.   
 
Abelson family kinases 
 The Abelson family kinases Abl and Abl2/Arg are non-receptor tyrosine kinases 
(NRTKs) that act as regulators of the cell cycle and actin cytoskeleton organization.  
Kinase activation is achieved by engagement of their SH2 domains, typically through 
binding RTKs, or SH3 domains.  Arg is of particular interest because it is enriched in 
dendritic spines and is known to maintain dendritic spines in adult mice103.  The SH2 
domains of Abl and Arg were shown in a yeast-two-hybrid assay to bind the 
phosphorylated juxtamembrane tyrosine residues of EphB2.  Their results were 
confirmed by in vitro pull-down assays104.  This study also demonstrated a positive 
feedback loop between EphB2 and Arg, whereby EphB2 phosphorylates Arg, which may 
then phosphorylate EphB2104.  Interestingly, no follow-up work has been done to study 
this interaction further, though some studies have characterized Abl as an important 
effector of Eph receptors.  Previous sections described Eph receptor-mediated inhibition 
of the adaptor Crk through Abl, which inhibited downstream Rho and Rap GTPases.  In 
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intestinal crypts, EphB signaling promoted proliferation of epithelial cells through Abl-
mediated activation of cyclinD1, a key regulator of the cell cycle102.  Abelson family 
kinases also interact with EphA4, as shown by the aforementioned yeast-two-hybrid 
study104.  This interaction is also of functional significance, because the Abelson family 
kinase inhibitor STI571 blocked retinal growth cone collapse downstream of EphA4 
activation105. 
 
Catalytically-inactive Eph receptors 
Two members of the Eph receptor family, EphB6 and EphA10, are catalytically-
inactive owing to mutations in conserved regions of their tyrosine kinase domains.  
Nonetheless, they contain their own signaling activities and contribute to the complexity 
and cell context-dependence of Eph receptor signaling106.  Studies, primarily of EphB6 
signaling, have shown that catalytically-inactive Eph receptors associate with, and are 
tyrosine phosphorylated by, catalytically-active Eph receptors and other non-receptor 
tyrosine kinases.  EphB1 and EphB4 bind and tyrosine phosphorylate EphB6, as do Src 
family kinases107–109. EphB6 is thought to be tumor-suppressive, as studies in various 
forms of cancer showed an inverse relationship between EphB6 expression levels and 
tumor invasiveness, particularly in breast cancer106,110.  A mechanistic explanation for 
these observations was described in a study that showed competition between EphB6 and 
EphB4 in modulating the invasiveness of breast cancer cells.  By signaling c-Cbl and Abl 
in an EphB4-dependent manner, EphB6 promoted breast cancer cell adhesion to 
fibronectin and reduced invasiveness in a Matrigel assay.  This opposed the pro-invasive 
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effects of EphB4109 and suggested that catalytically-inactive Eph receptors can associate 
with other Ephs to antagonize downstream signaling pathways.   
Unlike EphB6, EphA10 is thought to act as a tumor promoter.  Though the 
signaling pathways remain uncharacterized, its expression is up-regulated in multiple 
highly-invasive and metastatic cancers.  Normally, EphA10 is silenced in most tissues 
except for the testes, and it is thought that up-regulation of gene expression in some 
cancers may play a role in increasing invasiveness106.   
 
Negative regulation of Eph receptor signaling 
The primary mechanisms by which Eph/ephrin signaling is down-regulated are 
endocytosis of the receptors, proteolytic cleavage of Eph and ephrin extracellular 
domains, and de-phosphorylation of phosphotyrosines47. Receptor internalization by 
endocytosis is a typical outcome of RTK signaling.  Once internalized, receptors may be 
shunted to the endosomal pathway for degradation, or they can be recycled.  Eph/ephrin 
complexes display trans-endocytosis, in which the Eph- or ephrin-expressing cell 
internalizes the entire Eph/ephrin complex.  This process depends on Rac1 activity, and 
some data suggest that the Vav family of GEFs is specifically responsible for Rac1 
activation that leads to trans-endocytosis90,111.  The ubiquitin ligase Cbl, which contains 
SH2 domains, is also known to bind Eph receptors and contribute to their internalization 
and degradation in some contexts47.   
In some cases, extracellular proteolytic cleavage of Ephs or ephrins precedes 
internalization112.  Members of the matrix metalloproteinase (MMP) family and 
ADAM10 (a disintegrin and metalloproteinase 10) have been shown to cleave both Ephs 
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and ephrins to down-regulate signaling112.  MMPs are secreted or cell membrane-bound 
proteases that typically act on ECM or other membrane-bound proteins112.  MMP family 
members have been shown to cleave members of the EphA and EphB subfamilies, and 
cleavage sites identified in EphA2 and EphB2 lie within the FNIII repeat domains92,113.  
ADAM family proteases are membrane-bound and known to act on growth factor 
receptors, cell adhesion molecules, and other membrane-bound proteins112. One member 
of the disintegrin and metalloproteinase (ADAM) family, ADAM10, has been shown to 
cleave ephrin ECDs in numerous contexts112.  Studies have shown that ADAM10 weakly 
associates with Eph receptors, and that this association strengthens with Eph receptor 
activation and allows it to cleave ephrin ECDs in trans112.   
Proteolytic cleavage and/or internalization of the Eph/ephrin signaling complexes 
are thought to be necessary to convey repulsive cues in response to Eph/ephrin 
signaling47,92,111,112.  A study by Lin et al. (2008)92 showed that retraction of HEK293 
cells and growth cone collapse were inhibited by mutating EphB2 to render it resistant to 
proteolytic cleavage.  Pharmacologic inhibition of MMP-2 and MMP-9 produced similar 
results.  In another study, overexpression of dominant-negative Rac1 in human umbilical 
vein endothelial cells prevented trans-endocytosis of ephrinB2/EphB4 complexes and 
cell retraction111.  However, it was unclear if abrogation of cell retraction was due to the 
lack of endocytosis or the reduced Rac1 activity. If endocytosis or proteolytic cleavage is 
required to render cell-cell separation, it would be interesting to know if the persistence 
of complexes leads to signaling that promotes cell-cell adhesions, or if signaling during 
endocytosis somehow imparts repulsive cues. 
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Like most other RTKs, tyrosine phosphorylation of Eph receptor ICDs is 
negatively regulated by a variety of tyrosine phosphatases.   Major phosphatases that 
have been identified include low molecular weight protein tyrosine phosphatase (LMW-
PTP), protein tyrosine phosphatase, receptor type O (PTP-RO), and protein tyrosine 
phosphatase 1B (PTP1B)47,114. PTP-RO is thought to selectively de-phosphorylate 
juxtamembrane tyrosine residues in both EphAs and EphBs115, suggesting a role in 
negative feedback of tyrosine kinase activity.  Phosphatase activity may additionally play 
a role in directing adhesive or repulsive outcomes.  A study of EphA3 signaling in pre-B 
leukemia cells suggested that increased endogenous activity of  PTP1B changed the 
response from repulsion to adhesion116.   
 
Experimental techniques to cluster and activate Eph receptors 
The requirement for receptor clustering in Eph receptor signaling has led many 
groups to develop unique methods of inducing receptor clustering in vitro.  Use of 
antibody-clustered soluble ephrin ligands has been the most widely-used technique.  To 
accomplish clustering, the ECDs of ephrins are ligated to the crystallizable fragment (Fc) 
of human IgG.  These chimeras are dimerized by Fc cross-linking.  Pre-clustering of 
these dimeric ephrin-Fc chimeras by anti-Fc antibodies is done prior to treatment of cell 
cultures11.  An early study demonstrated an array of ephrin cluster sizes with antibody-
mediated clustering, with tetramers being the most effective to induce signaling42.   
Multiple studies have demonstrated that freely-diffusing ephrins are also 
sufficient to activate Eph receptors.  Co-culture studies of ephrin-expressing and Eph-
expressing cells, or of cell lines that contain an appropriate Eph/ephrin combination, have 
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shown contact-dependent activation of Eph receptors60.  In addition, studies have also 
shown that lipid substrates functionalized with ephrin ECDs are also sufficient to activate 
Eph receptor signaling in cells plated on top of them85.  This may reflect the 
aforementioned observations that ephrins are capable of self-dimerization54, and perhaps 
they may cluster on their own.   
Both of the techniques described above have been used to provide a plethora of 
information about Eph receptor signaling.  However, spatial and temporal regulation of 
signaling molecules are important to direct cell migration.  The nature of Eph/ephrin 
activation at cell-cell contacts necessitates sub-cellular regions of activation.  Thus, prior 
attempts have been made to achieve spatial and temporal control over Eph receptor 
clustering.  A study of contact inhibition of locomotion in prostate cancer cells simulated 
the nature of cell-cell contacts by functionalizing microbeads, which were coated with 
anti-Fc antibodies, with dimeric ephrin-Fc chimeras61.  Since these microbeads are much 
smaller than cells, these provided good models of sub-cellular cell-cell contacts and 
imparted some spatial regulation of signaling. Chemical induction of Eph receptor 
clustering was recently developed by inserting a variable number (one to three) of FK506 
binding protein (FKBP) domains between the transmembrane and juxtamembrane 
regions of EphB2 and treating with the cross-linking drugs AP20187 or AP188743.  
Depending on the number of FKBP domains inserted into the Eph receptor sequence, 
cross-linking produced clusters of different sizes.  This tunability of cluster size allowed 
the group to demonstrate that larger Eph receptor clusters generate stronger signals, and 
to provide further evidence that aggregates larger than dimers are necessary for efficient 
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signaling43.  This technique allowed some degree of temporal control over signaling, 
though drug treatments often exceeded 20 minutes, and there was no spatial control. 
Each of these techniques offered their own advantages in controlling Eph receptor 
signaling variables, though there is a role for additional techniques to combine multiple 
effects to achieve simultaneous spatial and temporal control.  Optogenetic techniques, 
specifically those that induce protein-protein interactions, have been used to gain spatial 
and temporal control over related receptor systems and cell signaling pathways.  Many 
applications have used the A. thaliana photoreceptor Cryptochrome 2, which will be 
described in the next section.       
 
Cryptochrome 2 in Optogenetics 
Optogenetics describes the use of genetically-encoded, light-sensitive proteins to 
control cellular signaling in vitro or in vivo using light, which is desirable to impart 
spatial and temporal control over signaling117. Perhaps most famously, use of light-
sensitive ion channels known as channelrhodopsins or halorhodopsins have been useful 
for in vivo applications in neuroscience, such as mapping and analysis of neural 
circuits118.  This discussion will focus on Cryptochrome 2, a blue light-sensitive 
photoreceptor from Arabidopsis thaliana that has been used to control protein-protein 
interactions with light. 
 
Cryptochrome 2 and CIB1 in optogenetics 
Cryptochrome 2 (Cry2) is a photoreceptor derived from Arabidopsis thaliana that 
undergoes a yet-uncharacterized blue light-induced conformational change that allows it 
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to bind the transcription factor CIB1119.  This property is imparted by its N-terminal 
photolyase homology region (PHR), which contains a flavin adenine dinucleotide (FAD) 
chromophore that is responsible for blue light absorption.  The protein also contains a C-
terminal nuclear localization sequence (NLS), which is mutated or truncated for 
optogenetic applications120.  
Blue light-induced Cry2-CIB1 binding has been used in mammalian cells to 
control protein translocation (Fig. 1.4, Movie 1.1) and protein-protein interactions using 
light. Optogenetic applications of the Cry2-CIB1 system were first demonstrated by 
Kennedy et al.120, who modified CIB1 by truncation (CIBN) to remove DNA-binding 
domains.  It was found that both truncated Cry2, leaving just the PHR, and full-length 
Cry2 (with a mutated NLS) bound CIBN upon blue light illumination.  Recruitment of 
Cry2 to the plasma membrane was demonstrated by tagging CIBN with a C-terminal 
CAAX (Ras) domain (Fig. 1.4).  Analysis revealed seconds-timescale Cry2 recruitment, 
with maximal plasma membrane signal ~15 seconds following a single photoactivation 
pulse.  The off-rate, however, was slow, as cytoplasmic recovery required ~12.5 
minutes120.  The functionality of these blue light-induced Cry2-CIBN interactions was 
demonstrated by blue light-induced gene expression using a split Gal4 promoter.  The 
DNA-binding domain of the promoter was ligated to Cry2, and the activation domain was 
ligated to CIBN.  A similar technique was used to achieve optogenetic control of Cre 
recombinase by splitting the enzyme120.     
Since this initial study, many groups have used the blue light-induced Cry2-CIBN 
binding to recruit proteins to the plasma membrane120 (Fig. 1.4, Movie 1.1) or control 
protein-protein interactions.  In general, CIBN is tagged to the plasma membrane as 
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shown in Fig. 1.4, and Cry2 is fused to a protein of interest in the cytoplasm.  Much 
attention has been paid to optogenetic manipulation of membrane lipids.  For example, 
Idevall-Hagren et al.121 used a fusion of Cry2 and phosphoinositide-5-phosphatase to 
recruit the phosphatase to the plasma membrane and dephosphorylate PIP2 to 
phosphatidylinositol-4-phosphate, PI(4)P.  PIP3 synthesis was also demonstrated by 
inducing plasma membrane recruitment of the inter-SH2 domain of the PI3K regulatory 
subunit (illustrated in Fig. 1.4).  The iSH2 domain, in this case, is bound to endogenous 
PI3K catalytic subunits, which are activated upon plasma membrane recruitment.  This 
technology was applied to show the effect of PI3K signaling on actin in axons and 
growth cones122.  Photoactivatable Akt, a downstream effector of PI3 kinase, was 
developed by ligating Akt to Cry2 and activating it by plasma membrane translocation123.  
Use of the Cry2-CIBN system has not been limited to membrane lipids.  Recently, 
molecular motors were recruited to intracellular vesicles to control anterograde or 
retrograde transport and their intracellular distribution124.  By using the previously-
described120 split galactosidase promoter, in vivo optogenetic control of gene 
transcription was achieved in zebrafish125.  Optogenetic inhibition and sequestration of 
proteins have also been explored.  Recruitment of RGS proteins to the plasma membrane 
achieved optogenetic inactivation of G protein-coupled receptors126.  Lee et al.127 
reported ligating CIB1 to a multimeric protein, in this case CaMKII, for blue light-
controlled sequestration of a target protein ligated to Cry2.  This technique was dubbed 
light-activated reversible inhibition by assembled trap (LARIAT) and was successfully 
applied to tubulin, Vav2, Tiam1, Rac1, RhoG, and Cdc42127,128.   
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 Use of the Cry2-CIBN optogenetic module resulted in an innovative optogenetic 
toolkit for a wide variety of applications.  The rapid timescale of Cry2-CIBN interactions 
and the ability to spatially define patterns of stimulation proved highly desirable to study 
cell signaling.  However, these modules required overexpression of two artificial fusions, 
which may have affected baseline cell behavior or caused technical problems with 
transfection, especially in the case of large proteins.  The next section will discuss the 
unique properties of Cryptochrome 2 that have permitted its use as a single-component 
module for optogenetic control of protein-protein interactions. 
 
Cryptochrome 2 clustering in optogenetics 
Recently, Cry2 was demonstrated to undergo blue light-induced clustering as a 
cytoplasmic Cry2-mCherry fusion129 (Fig. 1.4, Movie 1.2).  This clustering response was 
rapid- in response to repeated pulses of blue light, Cry2 clusters appeared within 10 
seconds and reached their half-maximal density in ~30 seconds.  The recovery rate, 
however, was much slower, as clusters dissipated with a ~5.5-minute time constant 
(exponential decay).  The significance of this clustering for optogenetics was 
demonstrated by controlling activation of β-catenin through clustering of an upstream 
protein, LRP6c, and activation of Rac1 and RhoA through clustering.  These techniques 
represented single-component optogenetic activation of intracellular proteins, a primary 
advantage of using Cry2 alone instead of the Cry2-CIBN module.  However, high 
concentrations of wild-type Cry2, or Cry2PHR, were necessary to observe efficient 
clustering130.  A later study reported that an E490G mutation in Cry2 (Cry2olig) 
enhanced blue light-induced clustering, though the half-time of cluster recovery was 
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extended from ~5.5 minutes to ~23 minutes in the cytoplasm130.   
In light of these discoveries, numerous applications that exploit this clustering 
property have been explored.  An assay dubbed light-induced co-clustering (LINC) was 
developed in conjunction with Cry2olig to query protein interactions by ligating the 
“bait” to Cry2olig-mCherry and the “prey” to another fluorescent protein130.  In response 
to blue light, the Cry2-fused bait clusters and, if the bait and prey interact, binds the prey 
by avidity, causing co-localizing clusters.  Fluorescence recovery after photobleaching 
was demonstrated in conjunction with LINC (LINC-FRAP) to study the kinetics of 
binding.  In another study, activation of C-RAF was demonstrated by Cry2-mediated 
clustering, but was also shown to occur via Cry2-CIB1 interactions131.  
Most recently, Cry2 clustering has been used to optogenetically control signaling 
from transmembrane proteins.  Receptor tyrosine kinases, for instance, are endogenously 
activated by ligand-induced dimerization and, in some cases, clustering.  Blue light-
induced activation of Trk receptors and FGFRs was achieved by ligating a Cry2-FP 
fusion to the C-terminus of these RTKs132,133.  Another strategy, called clustering 
indirectly using Cryptochrome 2 (CLICR), uses a two-component system to induce 
clustering and activation of transmembrane proteins (illustrated in Fig. 1.4).  Cry2 resides 
in the cytoplasm, fused to a protein or protein domain that interacts weakly with the 
receptor of interest.  Blue light-induced clustering, by avidity, then causes binding of 
these components and clustering of the transmembrane receptor.  This was demonstrated 
using β-catenin signaling and receptor tyrosine kinases, the latter by a cytoplasmic Cry2-
SH2 domain fusion134.  
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Chapter II of this thesis reports the development of a Cry2-based optogenetic tool 
for Eph receptor signaling.  This tool was used to study Eph receptors in the context of 
synaptogenesis at dendritic spines.  The following section provides an overview of the 
biology and development of dendritic spine synapses, and current knowledge of Eph 
receptor, particularly EphB, signaling in this field.  
 
  
Dendritic Spines and Filopodia 
Dendritic spines are the mushroom-shaped protrusions of neuronal dendrites that 
comprise the post-synaptic compartments of most excitatory, glutamatergic synapses in 
the central nervous system (CNS)1.  Structurally, dendritic spines contain a bulbous head 
that is attached to the dendritic shaft by a thin neck, and this structure is maintained by a 
dense actin cytoskeleton.  This morphology allows spines to compartmentalize post-
synaptic proteins and locally restrict post-synaptic signaling and electrical activity2,135.  
Post-synaptic molecules, including glutamate receptors, cell adhesion molecules, and 
important post-synaptic scaffolds, are concentrated at the post-synaptic density (PSD), 
which is directly opposed to the pre-synaptic axon135.   
Over time, dendritic spines undergo a phenomenon termed synaptic plasticity, 
defined as changes in synaptic strength.  Synaptic strength is modified by changes in 
spine head size and the density of glutamate receptors, which affects electrical 
conduction.  Long-term potentiation (LTP) describes synaptic strengthening by spine 
head enlargement and increased glutamate receptor content at the PSD.  Long-term 
depression (LTD) is the weakening or loss of a spiny synapses135,136.  LTP and LTD are 
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thought to play important roles in memory formation and loss, respectively, in vivo.  
Indeed, studies performed in vivo have shown changes in spine turnover and morphology 
following sensory stimulation and motor learning137–139. 
Dendritic spine density and shape are tightly regulated throughout development 
and adulthood in humans to ensure normal learning and cognition.  Abnormalities in 
spine density and morphology are frequently associated with neurological disorders3.   
For instance, Alzheimer’s Disease, a neurodegenerative disorder in older adults 
characterized by progressive dementia, is associated with abnormal loss of dendritic 
spines as an individual ages.  Fragile X syndrome, a genetic disorder that causes 
intellectual disability, is associated with an abnormally high density of spines that do not 
have well-formed spine heads3.  Thus, studying the mechanisms of spine formation, 
maintenance, and plasticity is crucial to understanding the underlying pathogenesis of, 
and developing treatments for, many neurological diseases.   
 
Dendritic filopodia 
Dendritic spines are thought to derive from dendritic filopodia, the long, thin, 
actin-based protrusions present on the dendrites of developing neurons135.  They are 
dynamic structures that have been observed to extend, retract, and bend on a timescale of 
minutes4,140.  The idea of dendritic filopodia as spine precursor structures was first 
suggested by observations of filopodia in cultured hippocampal neurons by Ziv and 
Smith in 19964. Some filopodia, though typically dynamic, were observed to stabilize 
upon contact with axons.  Additionally, filopodia density was highest during the first 
week in vitro and decreased during the second week, while dendritic spine density 
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increased concurrently4.  Electron microscopy studies of brain slices by Fiala et al. two 
years later reported synaptic structures juxtaposed to contacts between dendritic filopodia 
and axons5.  Thus, conventional wisdom holds that dendritic filopodia are dynamic 
structures that explore the area surrounding dendrites in search of axons.  A subset of 
filopodia becomes stabilized upon making contact, and these filopodia ultimately 
transform into dendritic spines4,5.    
Further studies of the actin structures and dendritic filopodia and spines provide 
more evidence supporting this model.  At the cytoskeletal level, dendritic filopodia 
resemble dendritic spines more than “conventional” filopodia associated with growth 
cones or lamellipodia135,141. Electron microscopy studies by Korobova and Svitkina 
(2010)141 showed that, unlike conventional filopodia, dendritic filopodia display some 
actin branching and do not contain the actin-bundling protein fascin.  Not surprisingly, 
given the presence of actin branching, the Arp2/3 complex is present in dendritic 
filopodia, as are myosin and capping protein.  This structure stood in stark contrast to the 
long, parallel bundles of actin typically observed in conventional filopodia, but compared 
well to the actin structure of dendritic spines141.  Spine heads contained highly-branched 
actin networks, with higher levels of the Arp2/3 complex and capping protein relative to 
the spine neck.  Perhaps the machinery necessary to form the highly-branched dendritic 
spine head, including Arp2/3142 and capping protein143, is present on dendritic filopodia 
to “prime” them for spine formation.  
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Dendritic spine morphogenesis from dendritic filopodia  
Mature dendritic spines are marked by a well-formed spine head and the presence 
of post-synaptic scaffolding proteins, such as PSD-95, and the NMDA- and AMPA- 
subtypes of glutamate receptors (NMDAR, AMPAR) in the PSD.  Studies showing the 
similarity in actin structure between dendritic filopodia and spines underscore the 
importance of actin reorganization to dendritic spine formation and synaptic plasticity. 
Spine head formation and enlargement are directed by increased actin polymerization in 
spines.  In particular, nucleation of highly-branched dendritic actin through activation of 
the Arp2/3 complex is important in the formation and expansion of spine heads135,142. 
Additionally, actin directs the organization of post-synaptic proteins at the PSD and 
membrane recycling of AMPARs, whose density in the PSD is correlated with synaptic 
strengh135,144.  
Certain patterns of neural activity are known to trigger synaptic plasticity.  For the 
sake of simplicity, spiny synapses that receive frequent glutamatergic input undergo 
maturation, or LTP, to become stronger and longer-lasting136.  Glutamatergic activity is 
also thought to account for initial formation of the spine head145.  Glutamate binding to 
NMDARs, which are ionotropic receptors, is thought to direct spine formation and LTP, 
in part, through an influx of extracellular calcium.  This causes activation of 
calcium/calmodulin-dependent protein kinase II, a master regulator of signaling cascades 
in dendritic spines that direct actin reorganization via the Rho GTPases Rac1, Cdc42, and 
RhoA.  This is accomplished through interacting with and phosphorylating GEFs6.  
Most signaling pathways that alter actin polymerization in dendritic spine 
morphogenesis and plasticity converge on the Rho GTPases Rac, Cdc42, and RhoA6,146, 
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which also mediate filopodia formation and motility.  Overexpression of dominant-
negative Rac and Cdc42 mutants in cultured neurons reduced spine density and caused 
immature dendritic protrusion morphologies15,147.  Rac and Cdc42 are known to mediate 
dendritic actin nucleation through the activation of Arp2/3 via the nucleation-promoting 
factors WAVE1 and N-WASP, respectively135,146–148.  Their effector p21-associated 
kinase (PAK) also positively influences dendritic spine formation6. RhoA-mediated 
inhibition of the actin-severing protein ADF/cofilin was shown to be critical for LTP 
induction135. RhoA is also known to signal myosin IIb through the activity of Rho-
associated protein kinase (ROCK). Inhibition of myosin IIb by blebbistatin caused 
replacement of spines by dendritic filopodia, suggesting an important role in maintaining 
spine morphology149.  
 It was observed that only a subset of dendritic filopodia that come into contact 
with axons form stable contacts4. A study8 that imaged a fluorescent calcium indicator in 
hippocampal slices revealed that stable contact formation between filopodia and axons 
was associated with a high frequency of local dendritic calcium transients.  Surprisingly, 
both contact stabilization and calcium transients occurred in the presence of NMDAR 
inhibitors8.  Since contact seemed to be a triggering event for filopodia stabilization, 
these results suggested a role for cell-cell recognition molecules in not only inducing 
these calcium transients, but also for directing contact stabilization and dendritic spine 
formation. A role for Eph receptors12, which were described in an earlier section, in 
dendritic spine formation was identified years before these results were published.  This 
is discussed in the following section. 
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EphB signaling in dendritic spine morphogenesis  
A synaptic function of EphBs was first suggested when the NMDAR subunit NR1 
was shown to immunoprecipitate with EphB2 from whole rat cortex and ephrinB1-
stimulated cultured cortical neurons20.  A later study established a role for EphBs in 
dendritic spine development by observing reduced dendritic spine density in hippocampal 
neurons overexpressing kinase-inactive EphB2.  This study also showed that EphB2-
mediated tyrosine phosphorylation of the proteoglycan syndecan-2 promoted spine 
formation13.  A follow-up study demonstrated severely impaired dendritic spine 
formation in dissociated primary hippocampal neurons and hippocampal slices from 
EphB1/B2/B3 triple-knockout (EphB TKO) mice14.  Interestingly, cultured neurons from 
single EphB (EphB1, B2, or B3) knockout mice showed no defects in spine formation or 
morphology, and double knockouts (different combinations of EphB1-B3) showed 
defects less severe than in triple knockouts.  Imaging of hippocampal slices revealed that 
triple EphB knockout was necessary to reduce dendritic spine density in vivo.  These 
results suggested that the various EphB isoforms show some redundancy in 
synaptogenesis.  Additionally, treatment of cultured neurons with pre-clustered ephrinB 
ligands increased dendritic spine density and spine head width, indicative of spine 
formation and maturation, respectively15.   
 Studies of the signaling pathways responsible for EphB-induced dendritic spine 
morphogenesis have converged on regulation of the Rho GTPases Rac1, Cdc42, and 
RhoA.  A summary is provided in Fig. 1.6.  EphB2 has been shown to interact with the 
Rac1 GEFs Tiam1 and kalirin-7 to affect dendritic spine morphogenesis and maturation, 
respectively15,150.  Treatment of cultured hippocampal or cortical neurons with ephrinB 
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ligands caused recruitment of these GEFs to EphB2 clusters15,147,150.  These interactions 
depended on an intact EphB2 intracellular domain, but did not require the PDZ binding 
motif, despite the fact that Tiam1 contains a PDZ domain151 and kalirin-7 has a PBM that 
binds other synaptic PDZ domain adaptors152.  It was recently shown that Tiam1 exists in 
a complex with the Rac1-specific GAP Bcr, and EphB2 disrupts this complex to increase 
Rac1 activation153.  Interestingly, Tiam1 and kalirin-7 are both tyrosine phosphorylated 
following EphB stimulation, though kalirin-7 showed no change in activity with this 
modification15,150.  It is thus questionable whether or not EphB2 stimulation of dendrites 
and interactions with GEFs and GAPs directly leads to Rac1 activation.  Use of the 
Raichu-Rac1 FRET sensor showed dendritic Rac1 activation with ephrinB ligand 
treatment153.  In another study, however, lysates of hippocampal neurons treated with 
ephrinB ligands showed no increase in active Rac1147.  Thus, the functional consequences 
of the interactions between EphB2 and Tiam1 or kalirin-7 are incompletely understood.  
Biochemical analysis of hippocampal lysates demonstrated Cdc42 activity with 
ephrinB treatment147.  EphB2 was shown to recruit the Cdc42-specific GEF intersectin 
into a complex with Cdc42 and N-WASP147, which then promotes F-actin nucleation.  
Intersectin-l was shown to bind syndecan-2147, suggesting a mechanistic link between the 
aforementioned interaction between EphB2 and syndecan-2 and dendritic spine 
morphogenesis.  The adaptor protein Numb was also shown to bind intersectin-1 and 
complex with EphB2 and NMDARs147,148, indicating that EphB2 may coordinate changes 
in actin polymerization with key electrophysiological elements of spine formation.  
Signaling from EphB2 to RhoA in dendritic spine morphogenesis remains 
controversial.  EphB2 signaling was shown to cause degradation of the RhoA-specific 
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GEF ephexin5 by UBE3A, thus promoting dendritic spine morphogenesis154.  
Surprisingly, another study showed RhoA activation by ephrinB treatment of cultured 
hippocampal neurons17.  Further study demonstrated that EphB2 activates RhoA via a 
complex containing Grb2, Src, focal adhesion kinase, and paxillin, to support dendritic 
spine morphogenesis and maintenance17,155.  The GEF responsible for activation in this 
complex remained unknown.  Presumably, degradation of ephexin5 by EphB2 did not 
preclude RhoA activation by additional mechanisms.  Perhaps the specific GEFs and 
adaptors involved are important for maintaining the proper spatial or temporal regulation 
of RhoA. 
In addition to regulating Rho GTPases, EphB2 signaling also affects the synaptic 
localization and function of the NMDA- and AMPA-type ionotropic glutamate receptors.  
EphrinB1-Fc treatment of cultured cortical neurons induced co-localization of EphB2 
clusters with the NR1, NR2A, and NR2B subunits of NMDARs, and EphB2 co-
precipitated from cortical lysates with NR120.  EphB2-NR1 binding was shown to be 
mediated by the extracellular domains of the proteins20. EphB2 uniquely causes tyrosine 
phosphorylation of the NR2B subunits, and increases current flow through and reduces 
desensitization of NR2B-containing, but not NR2A-containing, NMDARs in a kinase-
dependent manner19.  Synaptic and surface expression of NMDARs were also increased 
by EphB2 stimulation19,20.  Given the established role of EphB2 in dendritic spine 
morphogenesis, it seems that EphB2 signaling at axo-dendritic contacts may help the 
initial localization of NMDARs to nascent synapses.  Additionally, tyrosine 
phosphorylation of the NR2B subunit may potentiate the effects of glutamate, thereby 
facilitating spine head formation and LTP.  EphB2 has also been shown to co-localize 
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with, and increase the synaptic targeting of, AMPARs.  This interaction depends on the 
PDZ-binding motif of EphB2, through binding of the PDZ domain protein GRIP1156.   
This supports a role for EphB2 in synapse formation as well as maturation, since 
AMPAR levels typically increase in synapses as they mature1.    
 
EphB signaling in neuropathologies 
Given the association between dendritic spine morphogenesis and normal 
cognition and memory formation, it is not surprising that alterations in the EphB-Rho 
GTPase signaling axes are associated with psychiatric disorders and neurodevelopmental 
diseases.  Behavioral deficiencies and impaired hippocampal LTP were observed in 
EphB2-KO mice, effects that were, interestingly, kinase-independent157.  Development of 
schizophrenia, a psychiatric illness characterized by psychosis and mood and cognitive 
defects, was associated with copy-number mutations of EphB1158 and mutations of the 
EphB effector kalirin-7159.  UBE3A, which degrades tyrosine-phosphorylated ephexin5, 
is involved in numerous disorders.  Angelman syndrome is caused by a loss of UBE3A 
function, and autism spectrum disorders are associated with duplication of the UBE3A 
gene154.  These links to EphB function are, however, indirect, though missense mutations 
in EphB1 showed weak but insignificant correlations with schizophrenia159.  This may be 
explained by the redundant functions of the EphB isoforms in synaptogenesis14,159, such 
that simultaneous aberrations in multiple isoforms may be necessary to perturb function 
in a physiologically-significant manner. 
A number of studies have linked EphB2 to the pathogenesis of Alzheimer’s 
Disease, which is a neurodegenerative disease of old age characterized by severe 
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progressive dementia.  It is associated with abnormally reduced synapse density, the 
accumulation of extracellular plaques consisting of oligomers of amyloid-β, derived from 
the amyloid precursor protein, and neurofibrillary tangles composed of phosphorylated 
tau protein160,161.  In a mouse model of Alzheimer’s Disease, reduced EphB2 expression 
is observed prior to disease manifestation162.  Overexpression of EphB2 rescued 
behavioral defects and NMDAR-dependent LTP in Alzheimer’s Disease model mice and 
prevents changes in cultured hippocampal neurons secondary to Aβ-oligomer 
treatment163.  Signaling to PI3K by EphBs reduced Tau phosphorylation, such that EphB2 
was protective against AD progression101.  It is unclear if aberrations in EphB2 signaling 
are causal in, or the result of, AD progression, and further work is needed to clarify this 
role.  
 
EphB signaling and dendritic filopodia 
An elegant study by Kayser et al. (2008)16 knocked down EphB2 in cultured 
cortical neurons during different stages in development (days in vitro) and examined the 
effect on dendritic spine density in mature neurons.  This study showed that the ability of 
EphB signaling to promote spinogenesis was restricted to DIV7-14, when filopodia are 
most abundant4,16.  Additionally, overexpression of EphB2 in EphB TKO neurons was 
only effective to rescue dendritic spine density when performed at 3 DIV, rather than at 
10 DIV.  These results suggested a role for EphB signaling in dendritic spine formation 
that was specific to the presence of dendritic filopodia.  Therefore, observing how EphB 
signaling alters filopodia motility, morphology, or density is therefore important to 
understand how the filopodium-to-spine transition takes place. 
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A role for EphB signaling in dendritic filopodia formation is controversial.  EphB 
TKO neurons did not show an increase or decrease versus wild-type neurons of dendritic 
filopodia density16, indicating no effect on formation.  Findings of filopodia shortening 
with ephrinB1-Fc treatment of cultured hippocampal neurons17 suggests, at least, that 
EphB signaling does not promote filopodia formation.  Elongation would be expected 
from signaling that promotes filopodia formation.  However, increased overall dendritic 
protrusion density was separately reported in cultured hippocampal neurons following 
ligand treatment15.  Since protrusion density is a product of both formation and retraction, 
EphB signaling may have induced further protrusion formation or stabilized extant 
protrusions.  Only the increases in dendritic spine and synapse densities were explicitly 
quantified, such that an effect on filopodia formation could not be concluded. 
The same study by Kayser et al. (2008)16 that demonstrated a temporally-
regulated effect of EphB signaling on dendritic spine formation also quantified the effect 
of EphB TKO on the motility of dendritic filopodia.  This group found that filopodia in 
EphB-TKO cortical neurons were less motile than those of wild-type neurons, and that 
motility in the knockouts was rescued by overexpression of CA-PAK16.  This study 
indicated that EphB signaling may promote filopodia motility, thereby increasing their 
axon-searching function. Rac1 and Cdc42, which are the major upstream regulators of 
PAK, may play important roles in this regulation.  However, since the cultures were 
derived from EphB-TKO animals, all cells in the dissociated culture were devoid of 
EphB1-B3.  Given that EphBs are RTKs, their knockdown likely affected the expression 
of other proteins.  Therefore, the observed effects may have been indirect.  Additionally, 
a function for EphBs in stabilizing dendritic protrusions would be more consistent with a 
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role in spine morphogenesis.  Since EphBs are presumably activated at contacts, and 
filopodia stabilize at these contacts, one might expect a negative effect on filopodia 
motility.  On this note, knockout of EphBs may reflect an indirect effect of EphB 
signaling, such as the impact on expression of other genes, but not necessarily what 
happens upon ligand engagement at contacts.  
How EphB signaling to the Rho GTPases affects the motility and morphology of 
dendritic filopodia thus remains unclear.  As mentioned in the opening section, this thesis 
seeks to clarify this problem.  It is possible that EphBs direct the stabilization of filopodia 
upon contact with axons.  They may serve to contribute to dendritic spine head formation.  
Perhaps, even, the observed effects on the cytoskeleton are indirect.  My approach to this 
problem, and a summary of my findings, are described below.   
 
Overview 
As mentioned in the opening section, this thesis seeks to define the effect of EphB 
signaling on the motility and morphology of dendritic filopodia.  To approach this 
problem, we sought to gain spatial and temporal control over EphB signaling.  Even 
independently of their role in synaptogenesis, spatial and temporal regulation of signaling 
events is important to the biology of Eph receptors.  As cell guidance molecules, Eph 
receptors must establish gradients of downstream signaling mediators in individual cells 
to direct changes in cell migration164,165.  To achieve this goal, we used the blue light-
induced clustering of the Arabidopsis photoreceptor Cryptochrome 2129,130 to design an 
optogenetic tool, optoEphB2, to activate EphB2 signaling with spatial and temporal 
specificity.  Our data showed rapid tyrosine phosphorylation, expected cellular 
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phenotypes, and engagement of expected downstream effectors with optoEphB2 
photoactivation, confirming activation of EphB2 signaling. 
We used patterned blue light illumination to target activation of optoEphB2 to 
dendritic filopodia and sub-cellular regions of dendrites to simulate the nature of axo-
dendritic contact.  Stimulation of filopodia resulted in branching and expansion of 
filopodial tips in conjunction with F-actin accumulation.  Such results suggested 
formation of branched actin networks in filopodia, which would be expected in 
conjunction with spine head formation.  Stimulation of the dendritic shaft showed 
localized formation of filopodia-like structures that was dependent on the Arp2/3 
complex, which nucleates actin branches, and accumulation of the plasma membrane 
lipid phosphatidylinositol(3,4,5)-triphosphate (PIP3), which plays important roles in actin 
polymerization.  This suggests that EphB may direct formation of filopodia near sites of 
axo-dendritic contact, thereby up-regulating the local density of potential contacts that 
may develop into spines.   
Functional outcomes of EphB signaling are highly cell type- and context-
dependent.  While our observations suggested a role for EphB2 in promoting dendritic 
protrusions, Eph receptors as a whole are much better known for promoting repulsive 
responses between cells.  These responses would entail retraction of cell protrusions.  
Interestingly, prior studies and our data showed that plasma membrane PIP3 content is 
reduced downstream of EphB2 signaling when retractions occur.  Our results therefore 
also suggest that differential regulation of plasma membrane PIP3 content contributes to 
the context-dependence of EphB2 signaling in different cell types.    
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Figures 
 
Figure 1.1 
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Figure 1.1.  PI3K activation and signaling downstream of receptor tyrosine kinases.  
Receptor tyrosine kinases (RTK) frequently activate class I PI3 kinases through 
recruitment of the regulatory subunit (p85 shown).  This is typically accomplished by 
engagement of the regulatory subunit SH2 domains by RTK phosphotyrosines or through 
binding SH2 adaptors.  Catalytic subunits (p110) are constitutively bound to regulatory 
subunits and are activated by conformational changes in the regulatory subunit and 
recruitment to their plasma membrane substrates.  Ras GTPases are also known to 
increase PI3K activity through direct binding of Ras-binding domains in the catalytic 
subunits.  The catalytic subunits phosphorylate phosphatidylinositol(4,5)-bisphosphate 
(PI(4,5)P2, PIP2) on the plasma membrane to generate phosphatidylinositol(3,4,5)-
triphosphate (PI(3,4,5)P3, PIP3), which recruits downstream effectors via pleckstrin 
homology (PH) or other lipid-binding domains.  Important effectors include Akt and 
GEFs and GAPs that activate or inhibit, respectively, the Rho GTPases.  PIP3 can be 
dephosphorylated to PIP2 by PTEN, and is also dephosphorylated by many lipid 
phosphatases (not shown).   
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Figure 1.2 
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Figure 1.2.  Structure and clustering of Eph receptors and ephrins.  Eph receptors 
and ephrins are both membrane-bound molecules and are activated at cell-cell contacts.  
The two subtypes of ephrins, ephrinBs and ephrinAs, are structurally distinct.  EphrinBs 
are transmembrane proteins with unstructured intracellular domains that contain 
conserved tyrosine residues (Y) and PDZ-binding motifs (PBM).  These tyrosines 
become phosphorylated upon activation by other RTKs and non-receptor tyrosine 
kinases.  EphrinAs are linked to the outer leaflet of the plasma membrane by 
glycosylphosphatidylinositol (GPI).  The Eph receptor extracellular domain consists of 
the ligand-binding domain (LBD), a cysteine-rich domain (CRD) consisting of sushi and 
epidermal growth factor (EGF)-like motifs, and two fibronectin-type III (FNIII) repeats.  
The intracellular domain contains conserved tyrosine (Y) residues in the juxtamembrane 
(JM) region that are important for kinase regulation, a kinase domain, a sterile-alpha 
motif (SAM), and a PDZ-binding motif (PBM).  Autophosphorylation (pY) of the 
juxtamembrane tyrosines relieves intracellular autoinhibition, permitting substrate 
phosphorylation by the kinase domain. While dimerization of Ephs is sufficient to induce 
tyrosine phosphorylation, clustering is necessary for efficient signal transduction.  
Residues in the LBD, CRD, and the N-terminal FNIII allow these domains to promote 
clustering through cis receptor-receptor interactions.    
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Figure 1.3 
 
 
  
  53 
Figure 1.3.  Eph Receptor Pathways in Cell Adhesion, Migration, and Survival.  
Depending on the cell context, Eph receptors can increase or decrease cell adhesion, 
migration, proliferation, and survival through many of the same pathways activated by 
other RTKs.  These pathways most often converge on the Rho and Ras GTPases and 
PI3K.  EphAs activate the ephexin family of GEFs in multiple contexts to activate RhoA 
and promote cell-cell repulsion.  During growth cone collapse, 2-chimaerin is recruited 
to EphAs by its SH2 domain to inhibit Rac1.  However, Rac1 signaling is necessary for 
endocytosis of receptor-ligand complexes during cell-cell repulsion, and Vav family 
GEFs are thought to activate Rac1 in these situations.  Rac1 may also be activated 
through the GEFs DOCK1, associated with the SH2 adaptor Crk, and -Pix, which binds 
the SH2 adaptor Nck.  Nck may also signal PAK independently of Rac1 and Cdc42, 
which was shown in growth cone collapse downstream of EphBs.  When engaged by Eph 
receptors, Crk also promotes adhesion and activates integrin signaling through the Ras 
family GTPase Rap via the Rap-GEF C3G.  Signaling through the NRTK Abl can reduce 
cell adhesions by inhibiting Crk, dissociating it from C3G and p130Cas.  Abl, however, 
can also promote adhesions and increase cell proliferation through activation of cyclinD1.  
Unlike other RTKs, Eph receptors are generally known to inhibit Ras and R-Ras, 
typically by SH2 domain-mediated recruitment of p120RasGAP.  R-Ras inhibition can 
also occur by direct tyrosine phosphorylation.  These activities reduce cell survival and 
migration.  Activation of Ras may occur through recruitment of the SH2 adaptors Shc 
and Grb2, which bind the Ras-GEF SOS.  Src family kinases serve a variety of functions 
downstream of Eph receptors.  This figure displays Src-mediated tyrosine 
phosphorylation of ephexins and 2-chimaerin, which happens during EphA-mediated 
growth cone collapse, though SFKs are activated by Eph receptors in many systems and 
can phosphorylate a wide variety of downstream effectors.  Reduction of phosphotyrosine 
can occur through recruitment of protein tyrosine phosphatases, including LMW-PTP, 
PTP1B, and PTP-RO.  Multiple MMPs can cleave the ECDs of Ephs and ephrins, and 
ADAM10 can cleave the ECDs of ephrins, to down-regulate signaling and facilitate cell-
cell repulsion.   
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Figure 1.4 
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Figure 1.4.  Cryptochrome 2 in Optogenetics.  (a) Schematic showing blue light-
induced (blue arrows) binding between Cry2 and CIBN, a truncated mutant of the 
transcription factor CIB1.  In this example, CIBN is tethered to the plasma membrane and 
blue light illumination recruits Cry2.  (b) Confocal images of MCF7 cells co-transfected 
with Cry2olig-mCherry and a CIBN-GFP fusion tagged to the plasma membrane with a 
C-terminal CAAX sequence (K-Ras).  Blue light (488-nm laser used to image GFP) 
caused translocation of Cry2olig to the plasma membrane.  Total acquisition time was 
20.4 s.  Scale bar, 10 m.  (c) Schematic of blue-light induced (blue arrow) clustering of 
a Cry2olig-mCherry fusion.  (d) Confocal images of MCF7 cells transfected with 
Cry2olig-mCherry, which clustered in response to blue light illumination (458-nm laser, 
scanning simultaneously, 48.4 s acquisition).  Scale bar, 10 m.  (e)  Optogenetic 
activation of PI3K.  A CIBN-GFP-CAAX construct is tethered to the plasma membrane 
and co-expressed with a fusion between Cry2 and the inter-SH2 (iSH2) domain of the 
PI3K regulatory subunit.  The iSH2 domain binds endogenous PI3K catalytic subunits 
(p110), which become activated upon blue light-induced plasma membrane recruitment.  
(f)  Schematic of clustering indirectly using Cryptochrome 2 (CLICR).  Cry2 is tethered 
to a specific downstream effector of a transmembrane receptor (shown as example), or 
other protein of interest.  Blue light-induced clustering of these effectors causes binding 
to the receptor by avidity, thereby clustering and activating the receptor.  Confocal 
images (b and d) were taken on a Zeiss LSM510 confocal microscope, using a 488-nm 
laser line to excite GFP and a 561-nm laser line to excite mCherry.  
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Figure 1.5 
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Figure 1.5.  Dendritic filopodia make contact with axons and transform into 
dendritic spines.  (a) Dendritic filopodia are actin-based protrusions that arise from actin 
patches on the dendritic shaft.  (b) Dendritic filopodia extend, retract, bend, and 
sometimes branch in search of pre-synaptic axons.  Some filopodia form stable contacts 
with axons. (c) Dendritic filopodia that form stable contacts with axons undergo 
reorganization of the actin cytoskeleton to form dendritic spines.    
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Figure 1.6 
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Figure 1.6.  EphB signaling in dendritic spine morphogenesis.  EphBs signal GEFs 
and GAPs that regulate the Rho GTPases Rac1, Cdc42, and RhoA to drive dendritic spine 
morphogenesis. Interactions have been shown between EphBs and the Rac-GEFs kalirin-
7 and Tiam1, both of which are tyrosine phosphorylated by EphBs.  The Rac-GAP Bcr 
also interacts with Tiam1, and EphB2 disrupts this interaction.  EphB2, the Cdc42-GEF 
intersectin, and N-WASP form a signaling complex. Numb also binds EphB in complex 
with intersectin.  Both Rac1 and Cdc42 activate the Arp2/3 complex, through WAVE1 
and N-WASP, respectively, and PAK, to promote dendritic spine formation and 
maturation.  Regulation of RhoA activity by EphBs in dendrites is more complicated.  
EphBs are known to tyrosine phosphorylate the Rho-GEF ephexin5, leading to its 
UBE3A-mediated ubiquitination and degradation.  However, a signaling complex 
involving Grb2, Src, and focal adhesion kinase (FAK) was shown to activate RhoA 
downstream of EphBs via an unknown GEF. Downstream of RhoA, signaling through 
ROCK and myosin is thought to affect spine morphogenesis, whereas LIMK/cofilin 
signaling is thought to mediate spine stability.  In addition, EphBs also interact with 
syndecan-2 and glutamate receptors.  The ECDs of the NMDAR and EphB2 were shown 
to mediate binding, and EphBs were also tyrosine phosphorylate the NR2B subunit of 
NMDARs to alter their conductivity.  EphBs recruit AMPARs through the PDZ domain 
scaffolding protein GRIP.  Tyrosine phosphorylation of syndecan-2, a heparan sulfate 
proteoglycan that promotes dendritic spine formation, has also been shown.  EphrinB3 
was shown to interact with EphBs in cis to inhibit spine morphogenesis.     
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Movie Captions 
 
Movie 1.1.  Light-inducible plasma membrane recruitment of Cryptochrome 2.  
Movie shows Cry2olig-mCherry signal in MCF7 cells co-expressing CIBN-GFP-CAAX. 
Cells were imaged by confocal microscopy (Zeiss LSM510), co-scanning with a 488 nm 
(GFP excitation, Cry2 photoactivation) and 561 nm (mCherry excitation) lasers.  Rapid 
translocation of Cry2 to the plasma membrane was observed with blue light illumination. 
 
Movie 2.2.  Light-inducible clustering of cytoplasmic Cryptochrome 2.  Movie shows 
Cry2olig-mCherry signal in MCF7 cells. Cells were imaged by confocal microscopy 
(Zeiss LSM510), using a 561 nm laser to excite mCherry and simultaneously scanning 
with a 458 nm laser to photoactivate Cry2olig. Cry2olig showed rapid clustering in 
response to blue light.    
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CHAPTER II: Development of an Optogenetic Method for Eph Receptor Activation 
 
 
 
 
 
 
 
 
 
 
 
Attribution:  This chapter contains excerpts and figures from the manuscript “Effects of 
Localized EphB2 Activation on Dendritic Filopodia of Hippocampal Neurons” co-
authored by Clifford Locke, Qingfen Yang, Kazuya Machida, Chandra Tucker, Yi Wu, 
and Ji Yu.  Qingfen Yang assisted with cloning procedures.  Kazuya Machida ran the 
phosphotyrosine blot (Fig. 2.2b) of whole cell lysates, performed the rosette assay, 
constructed Figure 2.3a, c, and d, and edited the relevant portions of the Methods section.  
Chandra Tucker provided the Cry2 mutant, Cry2olig, ahead of her manuscript on its 
development.  Drs. Betty Eipper and Richard Mains provided embryonic rat hippocampi.  
The text was written by Clifford Locke and proof-read and edited by Ji Yu and Yi Wu.  
Clifford Locke wrote the text, constructed the figures that were not otherwise attributed, 
and performed all experimental work that was not otherwise attributed. 
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Abstract 
 Eph receptors comprise the largest family of receptor tyrosine kinases in 
mammals.  Together with their membrane-bound ephrin ligands, they transduce cell-cell 
contacts into changes in cell migration that affect cell positioning and tissue patterning 
during developmental processes.  Spatial and temporal regulation of Eph receptor 
signaling on the tissue and single cell levels is thus important to proper function, and 
current in vitro stimulation techniques do not permit this level of control.  Here, 
we develop an optogenetic tool (optoEphB2) that allows for light-controlled reversible 
activation of EphB2 through blue light-induced clustering of the plant photoreceptor 
Cryptochrome 2.  Biochemical analysis showed rapid blue light-induced tyrosine 
phosphorylation and engagement of SH2 domain-containing effectors typical of EphB2 
signaling.  OptoEphB2 also facilitated real-time monitoring of cellular responses to 
EphB2 signaling that was targeted to specific sub-cellular regions.  We thus developed a 
method for spatial and temporal control over EphB2 signaling.  
 
Introduction 
Eph receptors comprise the largest receptor tyrosine kinase (RTK) family in 
mammals, consisting of nine EphA and five EphB receptors10. They are named according 
to their relative binding affinities for either glycosyl phosphatidylinositol (GPI)-linked 
ephrin-A or transmembrane ephrin-B ligands, although it should be noted that receptor-
ligand binding is promiscuous and ligand specificities are not absolute22,166.  Because 
both the receptors and their ligands are membrane-bound molecules, Eph receptors have 
a unique property among RTKs that their signaling activation in vivo typically requires 
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direct cell-cell contact.  Additionally, Eph receptors rely on clustering for efficient signal 
transduction41.  While Eph receptor dimerization is sufficient for tyrosine 
phosphorylation, efficient effector recruitment and resulting cellular phenotypes typically 
require higher-order associations42,43.  During development, Ephs and ephrins sense cell-
cell contacts and alter the actin cytoskeleton to guide cell migration and thereby control a 
host of important biological processes, including axon guidance64,  tissue patterning65, 
angiogenesis167,  and cell proliferation102.  Dysfunction in Eph/ephrin signaling has been 
linked to many pathological processes, such as various forms of cancer and Alzheimer’s 
Disease24,168.   
Proper cell guidance by Eph receptors and ephrins relies on precise spatial and 
temporal control of their signaling, which is necessary during development to position 
cells in the right place at the right time.  On the tissue level, this is accomplished by 
spatial gradients of Ephs and ephrins, and has been well-described for the role of Eph 
receptors in axon guidance64.  For example, Ephs are thought to act as repulsive cues to 
guide retinal axons to their appropriate targets in the visual system, and this is important 
for spatial mapping of visual fields in the central nervous system (CNS)64.  In individual 
migrating cells, cell-cell contact typically occurs at sub-cellular regions.  Subsequent 
directionality inherently requires establishing spatial gradients of activated receptors and 
downstream signals across the cell165.    
Multiple techniques have been developed to cluster and activate Eph receptors in 
vitro.  In most studies, dimeric Fc-ephrin chimeras are pre-clustered by anti-Fc antibodies 
and then applied to cultured cells42.  This technique is most commonly used, but does not 
impart spatial or temporal control over signaling.  A chemical oligomerization system 
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was recently developed and used to tune cluster size and correlate it with signal strength.  
This system was designed with 1-3 FKBP domains inserted into the EphB2 ICD, which 
were cross-linked  with the homodimerizers AP20187 or AP188743.  This technique 
appears to provide temporal control, though most drug incubations were 20 minutes or 
longer, and spatial control was not demonstrated.  Additionally, antibody-coated 
microbeads have been used to pre-cluster ephrins and study cell migration61.  This 
technique simulates sub-cellular contacts, but does not permit temporal control and is 
impractical for non-migratory cell types, such as neurons.  Simultaneous spatial and 
temporal control over signaling would be invaluable to precisely model cell-cell contacts 
and study the dynamics of downstream signaling mediators.  
Recent concurrent studies reported spatial and temporal control of Trk 
receptors132 and FGFR133, other RTK family members, using the blue light-induced 
clustering of Cryptochrome 2 (Cry2).  Cry2 is a photoreceptor derived from Arabidopsis 
thaliana that clusters in response to blue light absorption by the flavin adenine 
dinucleotide (FAD) chromophore in its photolyase homology region (PHR)134.  Here, we 
report the development of optoEphB2, a genetically-encoded, photoactivatable EphB2.   
Blue light-induced clustering of optoEphB2 caused rapid tyrosine phosphorylation and 
recruitment of SH2 domain-containing effectors that typically bind endogenous EphB2 
receptors.  Retraction of cellular protrusions in fibroblasts and axonal growth cone 
collapse were also observed and agreed with studies that used ephrinB ligand stimulation.  
Signaling was reversible and repeatable, and spatial restriction of clustering and cellular 
phenotypes were demonstrated.  We thus developed a versatile module for spatial and 
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temporal control over EphB2 signaling that can be applied in a multitude of cellular 
systems. 
 
Methods 
Antibodies, reagents, and plasmids  
All chemicals used for the experiments were purchased from Sigma-Aldrich (St. 
Louis, MO) unless otherwise specified. The mouse anti-phosphotyrosine antibody was 
purchased from Cell Signaling Technologies (Danvers, MA).  The mouse anti-tubulin 
and rabbit anti-mCherry antibodies were purchased from Thermo Scientific (Waltham, 
MA).  IRDye 680- and IRDye 800-labeled secondary antibodies were purchased from LI-
COR (Lincoln, NE).  
Cry2olig-mCherry (full-length Cry2 or its PHR with E490G mutation), light-
insensitive Cry2-mCherry (Cry2 with D387A mutation), and wild-type Cry2-mCherry 
(full-length or PHR) were described previously120,129,130.  Human EphB1 (plasmid 
#23930) and EphB6 (plasmid #23931) sequences were obtained from Addgene 
(Cambridge, MA).  The human EphB2 sequence was obtained from DNASU (plasmid 
#80351).  To create optoEphB2 plasmids, the Gateway cloning system (Invitrogen) was 
used.  A Gateway cassette (Invitrogen) was first introduced into the Cry2-mCherry or 
Cry2olig-mCherry plasmids, N-terminal to the Cry2 sequences, to produce destination 
vectors.  An entry vector containing the myristoylation signal peptide was generated by 
inserting the oligonucleotide sequence corresponding to the N-terminal signal peptide of 
c-Src (MGSNKSKPK) into pDONR223 (Invitrogen).  Entry clones containing the ICD 
sequences of EphB1 (amino acids 564-984), EphB2 (amino acids 595-986), and EphB6 
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(amino acids 328-729), with N-terminal myristoylation, were then created using a 
standard PCR-based cloning procedure.  Finally, expression clones for optoEphB1, 
optoEphB2, and optoEphB6 were made by LR recombination (LR Clonase, Invitrogen) 
of the corresponding Cry2-based destination vectors and entry clones.  The kinase-dead 
optoEphB2 (KD-optoEphB2) construct was made by site-directed mutagenesis (K662M 
in full-length EphB2, K98M in optoEphB2).  To generate optoEphB2 clones containing 
Venus, mCherry was excised and replaced with the yellow-fluorescent Venus sequence, 
which was amplified by PCR.  A lentiviral vector carrying optoEphB2 (pLIX401-
optoEphB2) was made by excising the whole optoEphB2 sequence and subcloning it into 
an inducible lentiviral expression vector, pLIX401 (Addgene plasmid #41390).  The Arg-
YFP plasmid169 was a gift from Anthony Koleske.   
 
Cell culture, transfection, and ephrinB1 Treatment  
 All cells were kept in a humidified 37C incubator with 5% CO2.  HEK293, 
HEK293FT, MCF7, MEF, and COS7 cells were maintained in Dulbecco’s Modified 
Eagle Medium (Gibco, Grand Island, NY or Lonza, Basel, Switzerland) with 10% fetal 
bovine serum (FBS, BioWest, Kansas City, MO) and penicillin/streptomycin (Gibco) at 
100 U/ml penicillin and 100 g/ml streptomycin.  The medium used to maintain 
HEK293FT cells was DMEM/FBS supplemented with 500 g/ml G418 (Gibco).  
Transient transfections were carried out using Lipofectamine 2000 (Invitrogen, Grand 
Island, NY) following the manufacturer’s protocol.  To establish cells stably-expressing 
optoEphB2 and KD-optoEphB2, pseudo-lentiviral particles were prepared.  Briefly, 
pLIX401-based DNA was co-transfected into HEK293FT cells by calcium phosphate 
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precipitation with the 3rd generation packaging plasmids pRRE, pMD2G, and pRSV 
(Addgene plasmid #12251, #12259, #12253).  Viruses were precipitated from cell culture 
medium with PEG-it (400 g/L PEG 8000, 88 g/L NaCl) and concentrated by 
centrifugation.  The MEF Tet-off cells (Clontech, Mountain View, CA) were infected 
with viral particles to produce the MEF-OptoEphB2 and MEF-KD-OptoEphB2 cells, 
which were maintained in DMEM/FBS media supplemented with 300 µg/ml G418.  
Primary hippocampal neurons were plated and maintained as previously 
described170,171.  Briefly, hippocampi were dissected from E17-19 Sprague-Dawley rats 
and were mechanically dissociated.  Some hippocampi were obtained from BrainBits, 
and other tissue was a generous gift from Drs. Betty Eipper and Richard Mains.  Cells 
were plated onto plasma-cleaned 30-mm coverslips, that were coated with 0.05% poly-L-
lysine, at 90,000-100,000 cells/dish. Neurons were maintained in Neurobasal (Gibco) 
with B27 (Gibco) at 1:50, GlutaMax (Gibco) at 1:400, and penicillin-streptomycin at 100 
U/ml of penicillin and 100 g/ml streptomycin.  FBS at 2% and 25 M glutamate were 
also added at time of plating. Transfections were done using Lipofectamine 2000 and 
BrainBits (Springfield, IL) Transfection Medium, following manufacturer’s protocol with 
some modification.  Transfections of neurons were carried out 24-48 hours prior to 
experiments. 
 
Biochemical assays 
For western blot assays of phosphotyrosine, MEFs expressing optoEphB2 or KD-
optoEphB2 were treated with blue LED light (~10-2 W/cm2), or incubated in the dark, for 
1 minute.  Cells were lysed in modified kinase lysis buffer (KLB, 150 mM NaCl, 25 mM 
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Tris-HCl pH 7.4, 5 mM EDTA, 1 mM PMSF, 1% Triton-X-100, 10% glycerol, 0.1% 
sodium pyrophosphate, 10 mM -glycerophosphate, 10 mM NaF, 5 g/ml aprotinin, 50 
M pervanadate) as previously described172. 0.1% SDS was added to the KLB to aid in 
solubilizing large optoEphB2 or KD-optoEphB2 clusters.  Proteins from lysates were 
separated by gel electrophoresis on 4-15% gradient polyacrylamide gels (BioRad, 
Hercules, CA) in buffer containing 3.03 g/L Tris base, 14.4 g/L glycine, and 0.1% SDS.  
For loading into wells, 2-mercaptoethanol was added at 1:200.  Samples were transferred 
to nitrocellulose membranes (General Electric Healthcare, Pittsburgh, PA) in buffer 
containing 3.03 g/L Tris base and 14.4 g/L glycine.  Membranes were blotted with mouse 
anti-phosphotyrosine and rabbit anti-mCherry antibodies. Blots were visualized and 
quantified on an Odyssey IR scanner (LI-COR) using secondary antibodies labeled with 
IR dyes (rabbit IRDye 680 for mCherry, mouse IRDye 800 for pan-phosphotyrosine).  
The membrane was stripped in buffer containing 2% SDS, 62 mM Tris-HCl pH 6.8, and 
0.7% 2-mercaptoethanol at 55C, rinsed, and re-probed for anti-tubulin, which was 
visualized with a mouse IRDye 800 secondary antibody.   
Immunoprecipitation of optoEphB2 was carried out by first measuring the 
concentration of protein in cell lysates by colorimetry with Bradford reagent using a 
BioTek Synergy HT plate reader.  Cell lysate containing 200 g of protein was mixed 
with 2-4 g rabbit anti-mCherry antibody.  Pulldown was done with 25 L of protein A-
coated magnetic bead suspension (Invitrogen). Beads were pulled down using magnets, 
washed with KLB (no SDS), denatured at 95ºC for 10 minutes, in the same buffer used 
for gel electrophoresis plus 1:200 2-mercaptoethanol, and separated, transferred, and 
analyzed by the aforementioned western blotting procedure.  For photoactivation, MEFs 
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in a 6-cm dish were illuminated with blue LED light bulb of 1W total optical power for 1 
minute. Control cells were kept in the dark. 
The dot-blot SH2 binding assay was performed as previously described172,173  
using the lysates prepared for the phosphotyrosine assay.  Briefly, aliquots of the MEF 
lysates, or of lysates from pervanadate-treated cells (positive control) or phosphatase-
treated cells (negative control), were spotted on a membrane.  These aliquots were 
incubated with purified glutathione-S-transferase (GST)-tagged SH2 domains and 
detected by immunoblotting with horseradish peroxidase (HRP)-labeled anti-GST 
antibodies, treating with an enhanced chemiluminescence (ECL) reagent (Perkin-Elmer), 
and imaging on a Kodak Image Station 4000MM Pro with Carestream MI SE software. 
The quantification shown in Fig. 2.3d represents the average intensity from triplicates, 
normalized to the maximum signal derived from any of the optoEphB2 or KD-
optoEphB2 treatment conditions. 
 
Microscopy and Image Analysis   
Most live cell imaging experiments were carried out on a Nikon (Tokyo, Japan) 
Ti-E inverted fluorescence microscope with a 60x TIRF objective (NA = 1.49, Nikon).  
Images were acquired with an iXon Ultra EM-CCD (Andor, Oxford Instruments, 
Abingdon, Oxfordshire, UK).  The microscope was placed within a temperature-
regulated imaging chamber and cells were maintained at 37°C during imaging. For 
imaging mammalian cell lines, cells were kept in DMEM/F12 (Gibco) containing 2% 
FBS and 20 mM HEPES (Gibco).  For imaging neurons, the cells were kept in imaging 
medium containing 117 mM NaCl, 5 mM KCl, 1.25 mM NaH2PO4, 20 mM HEPES, 50 
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mM dextrose, 1 mM MgCl2, 2 mM CaCl2, and 100 mg/L BSA, at pH 7.2.  Neurons were 
imaged in epifluorescence, using a 575-nm LED (Lumencor, Beaverton, OR) to excite 
mCherry and mRFP and a 515-nm LED (Lumencor) to excite Venus.  MEFs were 
imaged in TIRF (total internal reflection fluorescence) mode.  A 594-nm DPSS laser 
(CrystaLaser, Reno, NV) was used to excite mCherry, and Venus/YFP was excited with a 
515-nm DPSS laser (CrystaLaser).    TIRF and DIC imaging of optoEphB2 clustering in 
293 and COS7 cells and ligand-mediated cell collapse in MEFs were carried out on an 
Olympus (Tokyo, Japan) IX81 TIRF microscope equipped with a 60x TIRF objective 
(NA = 1.49, Olympus) and a TE-cooled EM-CCD (PhotonMax, Princeton Instruments, 
Trenton, NJ).  The 488-nm line of an argon ion laser (Melles Griot, Carlsbad, CA) was 
used to excite GFP and photoactivate optoEphB2, a 562-nm DPSS laser (CrystaLaser) 
was used to excite mCherry, and a 442-nm DPSS laser (CrystaLaser) was alternatively 
used for photo-activation of optoEphB2.   
Spatial control of optoEphB2 on the Nikon Ti-E system was achieved using a 
Mosaic illumination system (Andor) coupled to a 440-nm LED (CoolLED, Andover, 
Hampshire, UK) on the Nikon Ti-E microscope, unless otherwise noted.  The region of 
illumination (ROI) was expanded to cover the whole mosaic for illumination over the 
field of view.  Photoactivation of sub-cellular regions and growth cones were 
accomplished by manually defining a ROI that encompassed the desired area.  For 
growth cones, the entire growth cone area was covered, and the ROI was adjusted as 
necessary for growth cone migration throughout the acquisition.  Images for whole-cell 
stimulation of MEFs were taken at 3 frames/min, with 50-ms pulses of photoactivation at 
3.5% LED power delivered between frames.  Growth cones were imaged at 6 frames/min 
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with 100-ms pulses of photoactivation at 2% LED power.  Alternatively, a 460-nm LED 
(Prizmatix, Givat-Shmuel, Israel), or the 488-nm or 442-nm lasers on the Olympus IX81 
system, were used for photoactivation where noted.    
Maximum intensity projections of growth cones were generated using ImageJ 
after background subtraction.  Area was measured with manual thresholding, and the 
same threshold was used for multiple projections from any one cell.  The growth cones 
were defined by the cellular area from the expansion point on the axonal shaft to every 
point touched by protrusive structures.  Two growth cones from the optoEphB2 group 
were excluded due to problems defining the expansion point.  MEF cell area was 
measured by measuring cellular area from the optoEphB2 signal after background 
subtraction and sharpening using the Unsharp Mask function.  Octane174 was used to 
count optoEphB2 clusters. 
 
Results 
Design of optoEphB2 
Eph receptors are typically activated in vitro by antibody-mediated clustering of 
soluble ephrin ligands prior to treatment11,41,42. We hypothesized that light-induced 
clustering would be sufficient for this, given the role of clustering in Eph receptor 
signaling, and to ultimately achieve spatial and temporal control. Two concurrent 
studies132,133 demonstrated activation of Trk receptors and FGFR, two other members of 
the RTK family, by fusing Cry2 to the receptors’ C-terminus.  We therefore ligated the 
PHR of Cry2, which will be referred to simply as Cry2, and mCherry to the C-termini of 
multiple Eph receptors (Table 2.1).  However, confocal microscopy of transfected 
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HEK293 cells revealed that Cry2 fusions involving EphB2 and EphB1 gave poor plasma 
membrane localization, and large fluorescent puncta were detected in the cytoplasm (Fig. 
2.1a).  We speculated that these puncta were internalization vesicles secondary to 
receptor activation.  This notion was supported by the fact that a construct consisting of 
EphB6, a catalytically-inactive EphB subtype, showed relatively more plasma membrane 
localization (Fig. 2.1a).  It was possible that activation of Eph receptors was occurring 
secondary to interactions with endogenous ephrins on other cells.  Alternatively, 
Himanen et al.56 demonstrated increased tyrosine phosphorylation of overexpressed Eph 
receptors.  Mutation of extracellular domain  (ECD) residues that are responsible for 
interactions between receptors on the same cell surface mitigated the tyrosine 
phosphorylation induced by overexpression56.   
We therefore eliminated the ECD and, instead, tagged the intracellular domains of 
the Eph receptors to the plasma membrane with an N-terminal myristoylation sequence 
derived from c-Src (Table 2.1).  A similar design was reported for optoFGFR133.  This 
modification improved plasma membrane localization (Fig. 2.1b).  However, 
photoactivation and imaging by total internal fluorescence (TIRF) microscopy showed 
that blue light-induced clustering was weak and inconsistent, insufficient for Eph receptor 
activation (Fig. 2.1c).  We then incorporated a recently-identified mutant, Cry2olig (Cry2 
E490G), which has a higher tendency to form high-order clusters130.  This was effective 
to produce robust blue light-induced clustering (Fig. 2.1c).  Two mutants of optoEphB2 
(Table 2.1), kinase-dead optoEphB2 (KD-optoEphB2) and a light-insensitive optoEphB2 
(LI-optoEphB2), were also constructed to serve as controls.  The kinase-dead construct 
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was made by introducing an arginine-to-methionine mutation in the ATP-binding pocket 
of the kinase domain (K98M in optoEphB2, K662M in full-length EphB2).   
 
Biochemical validation of optoEphB2 
The final design of optoEphB2 is shown in Figure 2.2a.  To test if optically-
induced optoEphB2 clustering resulted in receptor activation, we assayed for tyrosine 
phosphorylation in cell lysates of mouse embryonic fibroblasts (MEFs) stably expressing 
optoEphB2 or KD-optoEphB2. We found that optoEphB2-expressing MEFs subjected to 
blue LED light illumination for just one minute exhibited significantly higher overall 
tyrosine phosphorylation compared to cells left in the dark (Fig. 2.2b).  In contrast, blue 
light produced no increase in tyrosine phosphorylation in cells expressing KD-
optoEphB2 (Fig. 2.2a,b).  The most significant increase in phosphorylation was observed 
near 135 kDa, consistent with the size of optoEphB2.  Anti-phosphotyrosine blot analysis 
of immunoprecipitated optoEphB2 showed an approximately 29-fold increase of tyrosine 
phosphorylation (Fig. 2.2b) in blue light-illuminated samples.  These results verified 
optoEphB2 kinase activation by blue light-induced clustering.   
RTK phosphotyrosines typically serve as docking sites for Src homology 2 (SH2) 
domains of various adaptor proteins30.  For further biochemical validation of optoEphB2, 
we screened for candidate SH2 domains that interacted with proteins in the whole cell 
lysate.  To do this, we used a “rosette” assay as previously described172,173  (see 
Methods).  Our results (Fig. 2.3) showed, in response to blue light illumination of 
optoEphB2, significantly increased binding of SH2 domains that had been previously 
shown to bind EphB2, including Abl104, Arg104, Crk175, RasGAP50,71, and Nck50.  The 
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SH2 domains of CrkL, Cten, and Fes were also shown to bind the lysate, but have not 
been shown to interact with EphB2 in other studies.  CrkL and EphA3, however, were 
shown to interact176.  It is likely that these SH2 domains are binding other tyrosine-
phosphorylated proteins in the lysate, or that these are the result of non-specific binding.  
The SH2 domain of Src, whose binding of EphB2 is well-documented50,52,177, did not 
bind the cell lysate in our experiment, but also failed to bind the positive control, and the 
result is therefore inconclusive.  To confirm these results, optoEphB2 or KD-optoEphB2 
and Arg were co-expressed in 3T3 cells and formed co-localizing clusters upon blue light 
illumination (Fig. 2.3b).  These results show that SH2 domains that typically bind EphB2 
are also binding phosphotyrosine motifs in our cell lysates, providing further validation 
of optoEphB2.   
 
OptoEphB2 confers spatial and temporal control over EphB2 signaling 
We next asked if photoactivation of optoEphB2 produced the same cellular 
phenotypes as those caused by ligand-mediated activation. Previous studies have shown 
that a prominent cellular response to EphB activation is cell-cell repulsion, marked by 
local retraction of cell protrusions or cell collapse10. Consistent with these previous 
findings, we found that photoactivation of optoEphB2 in MEFs quickly induced cell 
collapse (Fig 2.4a, Movie 2.1).  OptoEphB2 clusters formed rapidly, with a time constant 
of 14.9 seconds (Fig. 2.4b), in response to repeated pulses of blue light.  Collapse of 
protrusions commenced with a delay of ~2 minutes following the first photoactivation 
pulse (Fig. 2.4b).  Quantification of cell area showed a greater than 60% overall 
reduction, on average, with optoEphB2 activation, with 4/6 cells tested losing greater 
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than 40% of cell area (Fig. 2.4b).  In contrast, KD-optoEphB2 caused significantly less 
cell collapse, and none of the cells lost more than 40% of their area (Fig. 2.4b).  Cell 
collapse was thus kinase-dependent as previously described10, and the KD-optoEphB2 
results also suggested that collapse was not an effect of phototoxicity.  Consistent with 
this finding, stimulation of MEFs expressing EphB2-EGFP with pre-clustered ephrinB1-
Fc ligands, but not the Fc control, caused retraction of cellular protrusions (Fig. 2.4c).  
The effects of optoEphB2 on cell morphology were also examined in HEK293 cells, in 
which EphB2 was previously shown to cause cell collapse175, and MCF7 cells, whose 
substrate attachment was reduced by ephrinB2 treatment178.  OptoEphB2 photoactivation 
also resulted in total collapse of HEK293 cells and reduced membrane ruffling and 
lamellipodial protrusions in MCF7 cells, and these effects were not observed with KD-
optoEphB2 (Fig. 2.4d,e).  To further rule out any effects of Cry2 or phototoxicity, 
photoactivation of a myristoylated Cry2-mCherry fusion (myr-Cry2-mCherry) also did 
not cause HEK293 cell collapse.  These results confirmed functional EphB2 signaling 
with blue light-induced optoEphB2 clustering.      
Spatial and temporal control over signaling drives the development of optogenetic 
modules.  When blue light illumination was restricted to sub-cellular regions of 
optoEphB2-expressing MEFs and MCF-7 cells using digital light patterning179, we found 
that both receptor clustering and cell retraction were spatially restricted to the region of 
illumination (ROI), while non-illuminated regions were unaffected (Fig. 2.5a,b, Movie 
2.2).  These results demonstrated the ability of spatially controlling EphB signaling with 
OptoEphB2.  To test if optoEphB2 signaling can be reversed, we optically activated 
MEFs and monitored the morphology changes after the removal of blue light illumination 
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(Fig. 2.5c, Movie 2.3).  We found that within ~5 min, the receptor clusters dissipated and 
the cell started to re-expand by generating highly dynamic membrane protrusions (Fig. 
2.5c, Movie 2.3). Furthermore, we found that the activation-deactivation cycles can be 
repeated multiple times (Fig. 2.5c). Therefore, optoEphB2 allows for reversible and 
repeatable activation of EphB2 signaling. This may be important to study the role of 
EphB2 signaling in cell segregation, for instance, to determine signaling functions once 
segregation is complete.  The reversibility of the clustering of Cry2olig itself had been 
previously examined130.  Interestingly, we found that the clusters of optoEphB2 
dissipated much faster than previously reported for cytoplasmic Cry2olig-mCherry130.  
The difference may reflect a change in spatial dimensionality from the cytosol (3D) to the 
plasma membrane (2D), or may be related to EphB2 domain interactions or downstream 
signaling events. 
 
OptoEphB2 causes growth cone collapse in hippocampal neurons 
To test whether OptoEphB2 is functional in neurons, we examined if OptoEphB2 
activation induces repulsive responses in axonal growth cones43,45,62,91,92.  Growth cones 
of DIV5 primary hippocampal neurons co-expressing OptoEphB2 or KD-optoEphB2 
(fused to Venus in lieu of mCherry) with mCherry (volume marker) were illuminated 
with blue light.  We acquired time-lapse images of the growth cones before and during 
photoactivation.  Growth cone collapse and retraction were frequently observed with 
optoEphB2 photoactivation, but not with KD-optoEphB2 (Fig. 2.6a, Movie 2.4).  To 
quantify these effects, we measured the total area explored by the growth cone before and 
after photoactivation (Fig. 2.6b).  Because growth cone morphology is highly dynamic, 
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the area was measured from maximum intensity projections of the image stacks, 
compiled from the 5-minute period prior to, and the final 5 minutes of, blue light 
illumination.  These projections plot the maximum intensity recorded at each pixel during 
the indicated 5-minute time frame and thereby account for each point that was touched by 
the growth cone.  We found that photoactivation reduced the maximum projection area in 
10/12 growth cones expressing optoEphB2 (Fig. 2.6c).  In 9/10 of growth cones with 
reduced dynamics, a loss of greater than 20% was observed.  With KD-optoEphB2, this 
magnitude of reduction was only observed in 3/8 cases, and 4/8 growth cones showed 
increased dynamic activity.  Normalizing the final 5 minutes of photoactivation to the 5 
minutes before, optoEphB2 reduced the area explored by growth cones to ~68% of the 
original value, on average, while KD-optoEphB2 caused a marginal (~3%) increase in 
dynamics (Fig. 2.6c).   These results confirm the role of optoEphB2 in reducing 
hippocampal growth cone dynamics, in agreement with published results for EphB243. 
To further understand this phenomenon, we classified growth cones into three 
categories: lamellipodial, filopodial or blunt (Fig. 2.6d), following criteria used by an 
earlier study180.  Growth cones classified as “lamellipodial” contained predominantly 
broad membrane extensions.  “Filopodial” growth cones contained only long filopodia or 
filopodia with small lamellipodial veils.  “Blunt” growth cones contained no filopodia or 
lamellipodia.  For highly dynamic growth cones, a classification was assigned to each 
frame of the time-lapse movie during the initial and final 5-minute segments, and the 
most frequent classification was chosen.  Only growth cones that were lamellipodial or 
filopodial to start were considered for analysis.  As shown in Fig. 2.6d, optoEphB2 
activation promoted a filopodial or blunt morphology, observed in 5/14 and 3/14 growth 
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cones, respectively, post-stimulation, compared to 2/14 filopodial growth cones prior.  Of 
the 12 growth cones that initially displayed lamellipodial morphology, optoEphB2 caused 
4 to switch to filopodial and 2 to blunt.  Only 1 of 7 lamellipodial growth cones became 
filopodial with KD-optoEphB2 stimulation, and none became blunt.  This suggests 
selective disassembly of dendritic actin networks in growth cones.   
 
Discussion 
 Receptor tyrosine kinases, such as the Eph receptors, are often spatially and 
temporally regulated to achieve desired signaling outputs165.  This is particularly 
important in cell migration, where asymmetric signaling over the cell is necessary to steer 
cells in the appropriate direction165.  Concurrent studies by the Heo group achieved 
spatial and temporal control over the Trk and FGF family of RTKs using 
optogenetics132,133.  Here, this technique is applied to Eph receptors, whose function in 
cell migration and requirement of clustering for signaling render Cry2-based clustering 
an ideal method for spatial and temporal control.  Interestingly, our design required 
Cry2olig, as opposed to wild-type Cry2 as reported for previous applications, for efficient 
clustering on the cell surface.  This held despite the fact that membrane-tagged wild-type 
Cry2 demonstrated efficient blue light-induced clustering (Fig. 2.4d).  It is possible, 
however, that wild-type Cry2 produced clusters small enough as to not be visible.  Or, the 
design of the construct itself may have prevented Cry2 interactions between molecules, 
perhaps by weak steric hindrance or limited degrees of freedom.   
 We used biochemical assays and microscopic imaging to ensure optoEphB2 
behaved similarly to endogenous EphB2 in live cells.  The SH2 screening assay revealed 
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that phosphotyrosine residues in photoactivated cell lysates were capable of binding the 
SH2 domains of Abl, Arg, Crk, CrkL, Cten, Fes, Nck, and RasGAP.  Since we are using 
whole cell lysates, our assay does not confirm or refute direct binding of these domains to 
optoEphB2, since any of these SH2 domains may be binding to phosphotyrosine residues 
on proteins other than, or concurrently with, EphB2.  Indeed, multiple proteins displayed 
increased tyrosine phosphorylation in response to optoEphB2 photoactivation (Fig. 2.2b), 
so a multitude of sites are available for binding.  The literature shows evidence of direct 
binding between EphB2 and the SH2 domains of Abl104, Arg104, Crk175, Nck50, and 
RasGAP50,71, and we thus suspect that they also bind optoEphB2 directly.    We suspect 
indirect interactions for the CrkL, Fes, and Cten SH2 domains.  However, we cannot 
make these conclusions outright.  
In practice, other techniques used to conclude direct binding to EphB2 are also 
problematic, if less so.  Prior EphB2-SH2 interaction assays frequently used pull-downs, 
which may show indirect binding and often involve overexpression of SH2 domains or 
use of GST-SH2 fusions, thereby artificially increasing SH2 domain concentrations.  
These assays are thus susceptible to non-specific interactions and false positives.  Other 
in vitro screening techniques, such as yeast-two-hybrid, may not reflect conditions in 
living cells.  As such, techniques using only the SH2 domains, including the rosette 
assay, may yield false negatives as well as false positives27.  So, although we cannot 
conclude direct binding with the rosette assay, we still conclude that the interactions 
observed are consistent with native EphB2 signaling.   
Interactions between EphB2 and Grb217, Vav290, and Src177,181 have also been 
reported in the literature, though their SH2 domains did not show statistically significant 
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binding of  optoEphB2 lysates.  For Src, this is not concerning because its SH2 domain 
also showed relatively weak binding to our positive controls (Fig. 2.3c,d).  The 
interaction with Grb2 was shown by immunoprecipitation from cultured hippocampal 
neurons, but involvement of the SH2 domain was not explored17.  Multiple other studies 
reported negative results for interactions between the Grb2 SH2 domain and EphB250,182.  
An interaction between Vav2 and both EphA4 and EphB2 were demonstrated by 
immunoprecipitation, and deleting the Vav2 SH2 domain blocked its interaction with 
EphA4.  This was not explicitly tested for EphB2, and its interaction with Vav2 was 
substantially weaker than it was for EphA490, suggesting that this may not be an 
important interaction.  Thus, despite the aforementioned problems with the rosette assay, 
there is substantial agreement between the SH2 domains that we detected and SH2 
domain binding interactions reported in the literature.  This leads us to believe that 
appropriate signaling pathways are being activated by optoEphB2.    
 As observed in many prior studies with ligand-induced EphB2 clustering, blue 
light-induced optoEphB2 clustering yielded a substantial (~30 fold) increase in tyrosine 
phosphorylation.  Only 1 minute of blue light illumination was necessary for this 
response, suggesting robust temporal control over EphB2 signaling. The chemical 
dimerization system, based on cross-linking FKBP domains inserted into Eph receptor 
sequences, appeared to require drug incubations of at least 20 minutes to fully activate 
the receptors.  Most studies use ephrinB1-Fc treatments in excess of tens of minutes to 
study Eph receptor signaling.  For example, ephrinB1-Fc stimulation of COS1 cells, 
which express EphB2 endogenously, required longer than 15 minutes to observe an 
appreciable increase in tyrosine phosphorylation71. However, ligand stimulation has been 
  81 
reported to act more quickly in some studies.  COS1 cell process retraction was initiated 
within 5 minutes of ephrinB1-Fc treatment72, for example.  Neuroblastoma cells 
overexpressing EphB2 showed increased tyrosine phosphorylation 5 minutes following 
ligand stimualtion50.  So, it is clear that, at least in some contexts, optoEphB2 offers a 
substantial advantage in temporal control. 
The other major advantage of optoEphB2 is spatial control.  This may only be 
achieved with soluble ligands by using special equipment to establish chemical gradients.  
Astin et al.61 studied contact inhibition of locomotion in prostate cancer cells by 
conferring spatial control with ephrin-coated microbeads.  While this technique was 
useful, it may not be extended to slowly- or non-migrating cells, and does not allow 
temporal control over stimulation. OptoEphB2 permits user-defined, on-demand regions 
of illumination to stimulate Eph receptors, representing a more efficient and customizable 
method.    
We thus conclude that light-mediated activation of optoEphB2 provides all the 
advantages of the aforementioned techniques, while limiting any drawbacks.  We 
demonstrated spatial control of signaling to user-defined regions of illumination and 
showed reversibility and repeatability of signaling, such that any rebound effects may be 
studied, where relevant.  Since Cry2 clustering is tunable using light power and pulse 
duration and frequency183 this technique may, too, be used to tune cluster size and study 
cell responses.  Additionally, transfection of multiple optoEph constructs allows for co-
clustering multiple Ephs simultaneously.  However, this optical technique is not without 
its flaws.  The off-rate of Cry2 clustering is slow, thus analysis of short-lived Eph 
receptor stimulation (less than tens of minutes timescale) is not possible.  Additionally, 
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the PDZ-binding motif is blocked by the Cry2-FP fusion, though our data suggest that 
expected cellular phenotypes and effector recruitment persist despite this modification.  
Overall, optoEphB2, and the other optoEphs, represent a versatile module for spatial and 
temporal control over Eph receptor signaling that may be applied in a variety of cell 
types.    
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Tables 
 
 
Table 2.1. Nomenclature of constructs used to design and test an optogenetic tool for 
EphB2 clustering and signaling activation.  KD, kinase-dead.  LI, light-insensitive.  Cry2 
or Cry2olig indicate the corresponding PHR, unless otherwise noted.  FP, fluorescent 
protein.  Myr, myristoylation sequence derived from c-Src.  EphR, Eph receptor.  ICD, 
intracellular domain. K→M, arginine-to-methionine mutation in the ATP-binding pocket 
at position 662 of EphB2, or position 98 of optoEphB2.  D→A indicates aspartate-to-
alanine mutation in Cry2 at position 387, rendering it insensitive to blue light by 
disrupting FAD binding.  This was done to full-length Cry2. *Versions containing full-
length Cry2olig were also made. 
 
 
  
Construct Diagram 
Cry2-mCherry  
Cry2olig-mCherry  
myr-Cry2olig-mCh  
EphB1/EphB2/EphB6-Cry2-mCh  
OptoEphB2*  
KD-optoEphB2*  
LI-optoEphB2*  
Cry2 FP
FPCry2olig
FPMyr Cry2olig
Cry2EphR FP
FPEphB2 ICD Cry2oligMyr
FPK à M Cry2oligMyr
D à A FPMyr EphB2 ICD
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Figures 
 
Figure 2.1 
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Figure 2.1. Design iterations for optoEphB2.  (a) Confocal microscopy images of 
HEK293 cells expressing full-length EphB1, EphB2, or EphB6 fused to Cry2-mCh.  
Most of the fluorescent signal appeared in punctate cytoplasmic structures with EphB2 
and EphB1.  EphB6 showed relatively improved plasma membrane localization.  (b)  
Confocal images of HEK293 cells expressing optoEphB2 with wild-type Cry2 or 
Cry2olig.  These constructs showed improved localization to the plasma membrane.  
Confocal images in (a) and (b) were acquired on a Zeiss LSM510 confocal microscope, 
using a 561-nm laser to excite mCherry.  (c) TIRF microscopy images of optoEphB2 
with wild-type (WT) Cry2 (COS7 cell) or Cry2olig (HEK293 cell) before and following 
blue light illumination.  COS7 cells were given 500-ms pulses of 488-nm laser light at 5-
second intervals for 85 seconds.  HEK293 cells were given three 250-ms pulses of 488 
nm light, 4.5 seconds apart. Scale bars, 10 µm. 
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Figure 2.2 
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Figure 2.2. Optogenetic activation of EphB2 tyrosine kinase activity.  (a) Illustration 
of optoEphB2 domain structure and the photoactivation process. Blue light illumination 
induces Cry2 clustering, which results in receptor autophosphorylation (Y, tyrosine and 
pY, phosphotyrosine) and downstream signaling.  ICD, intracellular domain. FP, 
fluorescent protein.  Cry2olig indicates full-length Cry2olig or the PHR of Cry2olig.   (b) 
Left: western blot analysis of whole cell lysates collected from MEFs stably expressing 
optoEphB2 or KD-optoEphB2 that were illuminated by blue LED light (~10-2 W/cm2), or 
left in the dark, for 1 minute.  Right: quantification of optoEphB2 phosphorylation. 
Relative tyrosine phosphorylation was assayed in optoEphB2 immunoprecipitates and 
quantified by dividing the phosphotyrosine signal by the mCherry signal. Error bars show 
SEM (n=3).   
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Figure 2.3 
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Figure 2.3.  OptoEphB2 signals SH2 domain proteins typical of EphB2.  (a) 
Illustration showing the position of each sample on any given rosette in the SH2 
screening assay (see Methods) performed on the MEF cell lysates.  Representative results 
(Arg) are shown with relevant controls. (b) TIRF microscopy images of NIH3T3 cells co-
expressing the indicated constructs prior to and following blue light illumination.  Bottom 
row shows overlay.  Scale bar, 10 µm.  (c) Rosettes for all SH2 domains tested.  (d) 
Quantification of rosette results.  Values represent mean intensity of triplicates, measured 
by densitometry, normalized to the maximum value of all experiments.  Error bars, SD.  
*p < 0.05 by two-way ANOVA.  KD-L, KD-optoEphB2 treated with 1 minute of blue 
light.  KD-D, KD-optoEphB2 left untreated (dark).  WT-L, optoEphB2 treated with 1 
minute of blue light.  WT-D, optoEphB2 left untreated (dark).  Error bars, SD.  
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Figure 2.4 
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Figure 2.4. OptoEphB2 activation causes reversible and repeatable cell collapse and 
retraction of cell protrusions. (a) Time-lapse TIRF images of optoEphB2 or KD-
optoEphB2 in MEFs during blue light illumination (50-ms pulses, 3 pulses/min.).  Black 
dotted lines trace initial cell area. (b)  Top: Quantification of mean normalized MEF cell 
area in response to blue light illumination of optoEphB2.  Area at each time point is 
normalized to the mean prior to photoactivation and averaged between cells.  Error bars, 
SEM.  Bottom: OptoEphB2 cluster density (gray triangles) in response to continuous 
pulses of blue light illumination.  Each time point is normalized to the mean cluster 
density prior to photoactivation and averaged between cells. This curve was fit (dotted 
line) using an exponential to calculate the time constant () of 14.9 seconds.  Error bars, 
SEM.  (c) DIC and TIRF microscopy images of MEFs transiently transfected with 
EphB2-EGFP that were treated with pre-clustered ephrinB1-Fc chimeras (left) or human 
Fc fragments (right) for 15 minutes.  TIRF image shows EphB2-EGFP signal prior to 
treatment.  Dotted black lines trace initial cell area. (d) Left: TIRF images of optoEphB2, 
KD-optoEphB2, or myr-Cry2olig-mCherry in HEK293 cells, before and 3 minutes 
following blue light illumination (two 1-s pulses at 460 nm, gray triangles, 6 
frames/min.).  Right: Quantification of HEK293 cell area, normalized to the mean prior 
to blue light illumination, and averaged between cells.  Error bars, SEM.  (e) TIRF and 
DIC images of MCF7 cells expressing optoEphB2.  TIRF images show optoEphB2 signal 
before and following photoactivation (100-ms pulses, 440 nm, 6 frames/min.). The 
kymographs correspond to the white dotted lines in the DIC images.  Blue dotted lines 
indicate the start of photoactivation.  Scale bars, (a), (c)-(e), 10 m (unless otherwise 
noted).    
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Figure 2.5 
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Figure 2.5. Local optoEphB2 photoactivation causes spatially-confined clustering 
and retraction of cell protrusions. (a)  TIRF images of optoEphB2 in MCF7 cells 
before and after focal blue light illumination (white circle, 10-ms pulses at 440 nm, 6 
frames/min, 25 min.). (b) Time-lapse fluorescence images of optoEphB2 (MEF), which 
was activated by blue light illumination (100-ms pulses, 6 pulses/min.) within the 
specified region of illumination (ROI, black circle).  Time labels are relative to the start 
of photoactivation.  (c)  Time lapse TIRF images (top) of optoEphB2 (MEF) that was 
photoactivated (100-ms pulses, 10-s intervals) over the indicated one-minute time 
segments (blue, bottom), which were spaced at 10-minute intervals.  Plot shows cell area 
over time, normalized to the average cell area prior to the first stimulation (2 minutes).  
Kymograph (bottom right) of the indicated region (dotted line) shows repeated formation 
and dissipation of clusters, as well as cell shrinkage and expansion.  Scale bars, 10 µm.  
  
  95 
Figure 2.6 
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Figure 2.6.  OptoEphB2 photoactivation causes growth cone collapse and retraction. 
(a) Time lapse fluorescence images of mCherry (volume marker) in growth cones during 
photoactivation (100-ms pulses, 3 pulses/min.) of co-expressed optoEphB2 or KD-
optoEphB2.  Examples of growth cone collapse and retraction in response to optoEphB2 
stimulation are shown.  Time labels are relative to the start of photoactivation. (b) 
Maximum intensity projections of mCherry (volume) signal growth cones, constructed 
from 5-minute time segments before, and at the end of, blue light illumination. 
Illustration at top shows a timeline of the acquisition, indicating the relevant 5-minute 
intervals (gray). (c) Plot shows normalized maximum projection area for each growth 
cone.  Maximum projection area for each growth cone was measured for the final 5 
minutes of blue light illumination, and this value was normalized to the maximum 
projection area calculated prior to blue light illumination.  Diamonds indicate means, 
error bars show standard deviations. *p < 0.05, t-test.  (d) Analysis of growth cone 
morphology before and after blue light illumination. Growth cones were classified as 
lamellipodial, filopodial, or blunt (see text).  Scale bars, (a), (b), (d), 10 μm.   
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Movie Captions 
 
Movie 2.1. OptoEphB2 photoactivation causes cell collapse in fibroblasts.  Blue light 
illumination (blue dot) of MEFs stably expressing optoEphB2 (Left) caused rapid cell 
collapse, which was not observed with KD-optoEphB2 (Right).  
 
Movie 2.2.  Spatial regulation of optoEphB2 stimulation.  Focal (blue circle at 2:00) 
blue light illumination (blue dot) of optoEphB2 in MEFs results in spatially-restricted 
clustering and cell protrusion collapse, without perturbation of the remaining cell area.   
 
Movie 2.3.  OptoEphB2 clustering and signaling are reversible and repeatable.  
OptoEphB2 (MEF) is illuminated with blue light for 1 minute at 10-minute intervals.  
After each illumination period (blue dot), there is rapid collapse of cell protrusions 
followed by recovery of cell area.  Repeated photostimulation causes additional collapse 
and recovery cycles.   
 
Movie 2.4.  OptoEphB2 photoactivation causes growth cone collapse and retraction. 
Movie shows mCherry (volume marker) signal in growth cones of DIV5 hippocampal 
neurons.  Photoactivation (blue dot) of optoEphB2 for 15 minutes resulted in growth cone 
collapse (Left) and retraction (Center). Photoactivation of KD-optoEphB2 (Right) did not 
affect growth cone dynamics. 
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CHAPTER III: Local EphB2 Signaling Induces Branching of 
Dendritic Filopodia, Expansion of Filopodia Tips, and Promotes 
Dendritic Filopodia Formation 
 
 
 
 
 
 
 
 
 
 
 
 
Attribution:  This chapter contains excerpts from the manuscript “Effects of Localized 
EphB2 Activation on Dendritic Filopodia of Hippocampal Neurons” co-authored by 
Clifford Locke, Qingfen Yang, Kazuya Machida, Chandra Tucker, Yi Wu, and Ji Yu.  
Qingfen Yang assisted with cloning procedures.  Chandra Tucker supplied the Cry2 
mutant, Cry2olig, ahead of her manuscript on its development.  Ji Yu performed the 
experiments and analysis that measured PIP3 levels in 3T3 cells and constructed Figure 
3.4a-3.4d.  Drs. Betty Eipper and Richard Mains supplied rat hippocampi.  Anthony 
Koleske provided Arg constructs and GNF2.  Ji Yu and Yi Wu proof-read and edited the 
text.  Clifford Locke wrote the text, constructed all figures that were not otherwise 
attributed, and did all experimental work that was not otherwise attributed.  
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Abstract 
Dendritic spines are believed to derive from dendritic filopodia by reorganization 
of the actin cytoskeleton and recruitment of post-synaptic molecules. Previous studies 
suggested that EphB signaling, initiated at contacts between axons and dendritic 
filopodia, plays a critical role in this transition.  However, the exact effects of EphB 
signaling on the motility and morphology of dendritic filopodia have not been clearly 
defined.  We used optoEphB2, an optogenetic module for spatial and temporal control 
over EphB2 signaling, to specifically stimulate EphB2 in dendritic filopodia and small 
regions of dendritic shafts.  Presumably, this would model local signaling at axo-dendritic 
contacts.  Using this strategy, we found that localized EphB signaling at dendritic 
filopodia promoted filopodia branching and plasma membrane expansion associated with 
F-actin accumulation. Activation along the dendritic shaft also promoted actin nucleation, 
but resulted in de novo formation of dynamic filopodia that was dependent on activation 
of the Arp2/3 complex.  Furthermore, we show evidence that local EphB signaling 
resulted in an activation of phosphoinositide 3-kinase (PI3K), which marks a key 
difference between signaling in dendrites and in fibroblasts, in which EphB signaling 
causes retraction of cell protrusions. Combined, these results provided direct evidence of 
actin polymerization in filopodia following EphB stimulation and suggested that 
differential PI3K activity is important to adhesion versus repulsion downstream of EphB 
signaling in neurons.    
 
Introduction 
In the central nervous system, EphBs are known to promote synaptogenesis and 
dendritic spine development12. Inhibition of EphB signaling via genetic deletion or over-
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expression of dominant-negative constructs resulted in reduced spine density and 
dysmorphic spines in hippocampal neurons13,14. In vitro activation of EphB receptors 
with pre-clustered ephrinB-Fc ligands rapidly increased the number of synaptic spines in 
cultured rat hippocampal neurons at DIV1015. These results suggested that EphB 
signaling at axo-dendritic contacts is a key event that drives the formation of dendritic 
spines. Initial contacts likely form between axons and dendritic filopodia, which are thin 
and transient actin-based protrusions on dendritic shafts that are most abundant in 
immature neurons4,135. Dendritic filopodia are highly motile and thought to actively “seek 
out” axons in order to establish contacts, which then may subsequently lead to EphB 
activation and development of spines5,12.  However, the exact effects of local EphB signal 
activation on the morphology and dynamics of dendritic filopodia have never been 
clearly defined, because in vitro activation of EphB receptors using soluble ligands 
inevitably induces signaling globally in all cell types and cellular compartments. In 
contrast, EphB signals in vivo, particularly at axo-dendritic contacts, are presumably 
highly localized.  
To examine dynamic responses of filopodia to local EphB signaling, we utilized 
optoEphB2 to activate EphB2 signaling with precise spatial and temporal control.  Signal 
activation in dendritic filopodia of hippocampal neurons, in contradiction to previously-
reported results in fibroblasts and growth cones, promoted actin polymerization that 
resulted in filopodia branching and membrane expansion.  Interestingly, focal 
illumination of dendritic shafts resulted in de novo formation of filopodia-like 
protrusions, associated with activation of PI3-kinase.  Inhibition of Arp2/3 and Arg, an 
upstream regulator of Arp2/3 signaling, also inhibited filopodia formation.  While EphB2 
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signaling caused an accumulation of the plasma membrane lipid 
phosphatidylinositol(3,4,5)-triphosphate (PIP3) in dendrites, a reduction of plasma 
membrane PIP3 was associated with cell process retraction in 3T3 cells.  These results 
suggested that differential regulation of PIP3 synthesis may account for the differences 
seen between dendrites and other cell types.  Our experimental results demonstrated the 
mechanistic link between local EphB signaling and actin polymerization and provided 
new insights into the role of EphB2 signaling in the dendritic filopodia-to-spine 
transition.  
 
Methods 
Antibodies, reagents, and plasmids 
Cloning of optoEphB2 and other optoEphB constructs, as shown in Figure 2.2a, is 
described in the Methods section of Chapter II.  The light-insensitive optoEphB2 
construct,  containing the Cry2 D387A mutation as previously described129, was made by 
subcloning fragments that contained the mutation into optoEphB2.  OptoEphB2 and KD-
optoEphB2 containing Cry2olig (full-length) were also made by subcloning DNA 
fragments containing the C-terminal segment missing in the truncated versions130.  These 
clones containing Cry2olig were used for optoEphB2 photoactivation experiments in 
neurons.  OptoEphB2-PBM was made by subcloning a DNA fragment containing the 
sequences for mCherry and the final 6 amino acids of EphB2 (IQSVEV) into optoEphB2, 
taking the place of mCherry.  The Lifeact-mCherry (plasmid #54491) construct was 
obtained from Addgene.  The PHAkt-mRFP plasmid was previously described
121.  The 
myr-mCherry plasmid was prepared by recombination between an entry vector 
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containing the myristoylation sequence and a destination vector containing mCherry 
(Addgene plasmid #31907).  The Arg-YFP and kinase-dead Arg-YFP (ArgKD-YFP) 
sequences169,184 were gifts from Anthony Koleske.  The kinase-dead Src-YFP (SrcKD-
YFP) plasmid was a gift from Yi Wu.     
 
Cell culture, transfections, and drug treatments 
Protocols for extraction, culture, and transfection of hippocampal neurons are 
described in the Methods section of Chapter II.  For treatment of neurons with LY294002 
(Tocris) and DMSO, neurons transfected with optoEphB2 were initially photoactivated to 
confirm protrusion formation and PHAkt accumulation.  Cultures were then incubated in 
the dark for at least 20 minutes to allow optoEphB2 clusters to dissipate, and were then 
treated for 30 minutes with 50 µM LY294002 or a 1:200 dilution of DMSO, representing 
the dilution factor from a 10 mM stock of LY294002.  Photoactivation was then repeated 
over the same region of illumination.  Treatment with 5 µM cytochalasin D was initiated 
immediately following the first photoactivation and continued for 30 minutes.  For CK-
666 and GNF-2 (gift from Anthony Koleske) treatment in conjunction with dendritic 
shaft stimulation, neuronal cultures were pre-treated with 200 µM CK-666 or a 1:50 
dilution of DMSO for 30 minutes, or 10 μM GNF-2 or 1:1000 DMSO for 1 hour, prior to 
photostimulation.  
 
Microscopy and image analysis 
Imaging conditions and photoactivation equipment are described in the Methods 
section of Chapter II.  To illuminate filopodia, ROIs were defined along the length of the 
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dendrite, placed just far enough to avoid direct shaft stimulation, though spatial 
confinement was not perfect.  For focal illumination of dendritic shafts, the mosaic was 
used to deliver blue light to a 40-pixel-diameter (~266 nm/pixel) circular region, unless 
otherwise noted.  Images for all dendritic shaft stimulation experiments were acquired at 
3 frames/min, unless otherwise noted, and filopodia stimulation was acquired at 6 
frames/min.  Photoactivation was delivered in 50-ms pulses between frames, at 1% LED 
power, unless otherwise noted. 
Maximum intensity projections were generated after background subtraction and 
drift correction using the “BG Subtraction from ROI” and the “StackReg” plugins, 
respectively, in ImageJ.  Images were sharpened using the “Unsharp Mask” function.  
Maximum projection areas were measured within the ROI, using the same threshold 
value for any given cell.  Neurons were excluded if the dendritic shaft deformed within 
the ROI during the acquisition. Only protrusions with greater than 0.5-μm length were 
considered filopodia and analyzed for density or Lifeact content.  Lifeact accumulation 
was quantified by the mean Lifeact-mCherry intensity along a linescan that was manually 
drawn along the center of a filopodium from base to tip.  This was done for each 
filopodium adjacent to, or falling within, the ROI at the first and last frames of 
photoactivation.  In the case of plasma membrane expansion, a region of interest was 
drawn around the protrusion and the mean signal was quantified.  For each cell, the mean 
filopodium intensity for the final frame was normalized to that of the first frame, and 
values were averaged between cells.  Filopodia were examined for branching throughout 
the photoactivation period, and only those filopodia within the ROI for greater than three 
imaging frames were included.  PHAkt-mRFP and mCherry accumulation were measured 
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by normalizing the average intensity in the ROI, frame-by-frame, to the mean intensity 
within the ROI throughout the 5-minute period prior to photoactivation.   
 
Results 
OptoEphB2 activation in dendritic filopodia induces actin polymerization that results in 
branching and plasma membrane expansion 
To understand effects of local EphB activation in dendritic filopodia, we 
expressed either optoEphB2 or KD-optoEphB2 in DIV9-11 hippocampal neurons and 
monitored cell morphology changes after signal activation. Cells were co-transfected 
with either myr-mCherry, used as a membrane marker, or Lifeact-mCherry, to monitor 
actin polymerization. Filopodia were stimulated by targeting blue light to a region of 
illumination (ROI) oriented lengthwise along, but offset from, the dendritic shaft, and 
imaging the optoEphB2 and KD-optoEphB2 signals showed confinement of clustering to 
filopodia (Fig. 3.1a).  To our surprise, we found that stimulation of optoEphB2 in 
filopodia resulted in a ~2-fold increased probability of filopodia branch formation (Fig. 
3.1b, Movie 3.1), in comparison to the KD-optoEphB2 control. In some protrusions, 
broadening of filopodia was observed, with formation of lamellipodia-like structures in a 
small number of cases (Fig. 3.1e, Movie 3.2).  The next section describes filopodia 
formation following optoEphB2 clustering on the dendritic shaft.  No changes in 
filopodia density were observed with stimulation at dendritic filopodia (Fig. 3.1c), further 
confirming the desired spatial regulation.  Dendritic filopodia are supported by a dynamic 
actin cytoskeleton141. Therefore, we suspected that the observed changes in filopodia 
morphology were caused by nucleation of actin filaments.  To further characterize the 
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effect of EphB2 on actin cytoskeleton, we quantified Lifeact-mCherry signals in filopodia 
before and after blue light illumination. Significant accumulation of Lifeact signal (~57% 
increase) was observed with OptoEphB2 stimulation in filopodia (Fig. 3.1d,f, Movie 3.1), 
indicating increased F-actin concentration.   
 
Local EphB2 signaling in dendritic shafts induces dynamic filopodia-like protrusions 
EphB2 is expressed extensively along the dendritic shafts of hippocampal 
neurons18.  We therefore further examined whether EphB2 activation in the dendritic 
shaft may also affect the actin cytoskeleton and cell morphology.  Localized blue light 
photoactivation (~10 µm diameter) was delivered to dendritic regions of DIV10-11 
hippocampal neurons co-expressing mCherry, or Lifeact-mCherry, with either 
optoEphB2, KD-optoEphB2, or light-insensitive optoEphB2 (LI-optoEphB2, contains 
Cry2 with inactivating D387A mutation, see Table 2.1)129. We found that photoactivation 
of optoEphB2 locally induced formation of dynamic dendritic protrusions that resembled 
filopodia (Fig. 3.2a-c, Movie 3.3).  This phenotype was not observed with KD-
optoEphB2 (Fig. 3.2a,c) or LI-optoEphB2 (Fig. 3.2a), indicating that the effect requires 
both clustering and kinase activity, and is not an effect of phototoxicity.  In neurons co-
transfected with Lifeact-mCherry, Lifeact accumulated in a punctate distribution on the 
periphery of the dendrite in the ROI (Fig. 3.2b), indicating increased actin nucleation at 
the base of newly-formed filopodia.  
To quantify these morphological changes in dendrites, we generated maximum 
intensity projection images over 5-minute segments of time-lapse images both before and 
during the 15 minutes of photoactivation (Fig. 3.2b). The cellular area of a maximum 
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intensity projection is affected by changes in the morphology and dynamics of the 
dendritic filopodia, thereby measuring the area explored by the filopodial protrusions.  
We found that the cellular area, including the area of dendritic shaft and the areas 
explored by filopodial protrusions, increased significantly (~25%) after optoEphB2 
activation, and became progressively larger during the 15-minute photoactivation period 
(Fig. 3.2d).  This occurred in a kinase-dependent manner, as KD-optoEphB2 did not 
produce such an effect.  After stimulation and letting the cells sit in the dark for 20 min, 
we found that the number of dynamic filopodia was reduced to the pre-stimulation level.  
A second round of blue light stimulation promoted new filopodial growth, indicating that 
the stimulation is reversible and repeatable (Fig. 3.2e), as previously demonstrated in 
MEFs (see Fig. 2.4).  Finally, we also found (Fig. 3.2f) that the induction of filopodia can 
be blocked by treatment with CK-666, an inhibitor of Arp2/3 complex, suggesting that, 
similar to stimulation in filopodia, EphB2 activation in dendritic shaft also induces 
branched actin nucleation, which in turn gives rise to formation of new filopodia185. 
Additional tests were performed on other EphB family receptors. We found that 
focal blue light illumination of hippocampal dendrites expressing optoEphB1 led to 
filopodia formation in a similar manner to optoEphB2 (Fig. 3.3), while stimulation of 
optoEphB6 did not produce filopodia formation (Fig. 3.3). EphB6 is different from all 
other EphB members in that it is the only member that does not have a functional kinase 
domain. Thus the results further verified that the kinase activity of EphBs is essential for 
the effects on actin cytoskeleton.  Additionally, these observations are consistent with 
prior observations of functional redundancy among EphB isoforms in dendrites14.  Since 
the design of optoEphB2 blocks the C-terminus of the PBM, which is known to link 
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EphB2 to downstream effectors and PDZ scaffolds that additionally bind glutamate 
receptors, we wanted to confirm that our observations would hold with PBM-mediated 
interactions.  We thus subcloned the six C-terminal amino acids of EphB2 (IQSVEV), 
containing the PBM (VEV), into the C-terminus of optoEphB2 (optoEphB2-PBM).  We 
suspected that PDZ binding would be restored, given the ability of isolated PBMs to bind 
their respective PDZ domain partners186.  Additionally, overexpression of an EphB2-YFP 
fusion, in which YFP was inserted N-terminal to the PBM, was able to rescue spine 
formation in EphB1-B3 triple-knockout neurons16. Local stimulation of optoEphB2-PBM 
recapitulated the filopodia formation seen with optoEphB2 (Fig. 3.3), further validating 
the physiologic relevance of our observations. 
 
Differential regulation of PIP3 synthesis underlies cell context-dependent effects of 
EphB2 signaling on the actin cytoskeleton 
We observed that optoEphB2 photoactivation increased protrusive activity in 
dendrites and caused collapse of protrusive structures in growth cones and MEFs.  This 
raises the question of how downstream EphB signals cause such differences in 
phenotype.  Lin et al. recently studied EphB2-mediated CIL (contact inhibition of 
locomotion) in motile cells and identified down-regulation of phosphatidylinositol-
(3,4,5)-triphosphate (PIP3) synthesis as a key downstream pathway
98.  Therefore, we set 
out to investigate whether the effect on PIP3 synthesis is cell type-specific. First, we 
sought to confirm that optoEphB activation also suppress PIP3 synthesis in fibroblasts 
(Fig. 3.4a-d). Using a PIP3 sensor, the pleckstrin homology domain of Akt (PHAkt) 
labeled with mRFP (PHAkt-mRFP)
121,174, and total-internal-reflection fluorescence (TIRF)  
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microscopy, we measured the spatial distribution of PIP3 in 3T3 cells (Fig 3.4a). As 
expected, elevated PIP3 signal was found at the leading edges of cell protrusions, which is 
evident from the intensity linescans (Fig. 3.4b) perpendicular to the edge of cell 
protrusions. Upon optoEphB2 activation, we observed a rapid (< 1 min) decrease of 
PHAkt intensity at the leading edge (Fig 3.4b). Importantly, the reduction of PHAkt 
intensity preceded the retraction of cell protrusions.  Retractions were initiated after 1 
minute of stimulation (Fig. 3.4b).  On average, we observed ~20% decrease in PHAkt 
intensity during the first minute of photoactivation (Fig. 3.4c) near the leading edge (1 
µm from the cell edge). A smaller decrease was also observed at the interior of the cells 
(5 µm from cell edge), but the decrease was not statistically significant (Fig. 3.4d). 
Overall, these results confirm the recent study98 and indicated that optoEphB2 elicits a 
similar pathway to EphB2.   
Different results were observed in hippocampal dendrites using the same PIP3 
sensor. In DIV10-11 hippocampal neurons, we found coincidental PHAkt accumulation in 
the ROI (Fig. 3.4e-g, Movies 3.3-3.5) when we activated optoEphB2 and observed 
formation of filopodial protrusions. Epi-fluorescence microscopy was used here because 
TIRF microscopy was not suitable for imaging dendrites, which are not adherent to glass 
substrates. Therefore, the intensity of a volume marker, mCherry, was also measured to 
control for a potential artifact due to volume changes. We found that the average signal 
change is 29.8% for PHAkt, compared to 5.0% for mCherry, after 15 minutes of blue light 
illumination (Fig. 3.4f), suggesting that volume change was not a significant factor and 
PIP3 accumulation was primarily responsible for the PHAkt signal increase.  Therefore, 
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regulation of PIP3 synthesis downstream of EphB2 is cell type-dependent and may play a 
role in regulating adhesive versus repulsive responses downstream of EphB2 activation. 
To further validate the role of PIP3 synthesis in the observed signal outcome, we 
used a PI3K inhibitor, LY294002, to block PIP3 synthesis. To minimize effects of cell-to-
cell variability, we performed the comparison experiments on the same dendrite in a pair-
wise fashion. Specifically, we first performed focal photoactivation of optoEphB2 as 
described earlier to confirm the induction of actin polymerization and filopodia growth.  
The cells were then incubated in the dark for at least 20 minutes to disperse optoEphB2 
clusters, followed by treatment with either LY294002 or DMSO (control) and re-
stimulation of the same ROI (Figure 3.5a,b).  Quantification of PHAkt intensity in the ROI 
showed that LY294002 treatment eliminated PHAkt accumulation, which was maintained 
in DMSO-treated controls (Fig. 3.5a,b, Movies 3.3 and 3.4).  In addition, LY294002 
treatment resulted in abrogation of filopodia formation (Fig 3.5a,b). Finally, to see 
whether the induced PIP3 synthesis was upstream of F-actin synthesis, as opposed to be a 
consequence of it187, we inhibited actin polymerization using cytochalasin D during the 
second round of stimulation (Fig. 3.5c, Movie 3.6).  Yet, we still observed increased PIP3 
signal comparable to the first round of stimulation (Fig. 3.5c). Therefore, we conclude 
that PI3K activity was necessary for both the observed PIP3 synthesis, and formation of 
optoEphB2-induced protrusions.  
 
Filopodia formation by optoEphB2 depends on Abelson family kinases 
 Our previous experiments established a role for Arp2/3 activity in filopodia 
formation downstream of optoEphB2 and binding of phosphotyrosines in cell lysates to 
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the SH2 domain of Arg.  Arg, also known as Abl2, is a non-receptor tyrosine kinase 
(NRTK) that enriches in dendritic spines and functions in dendritic spine stability and 
maintenance103.  Arg is known to activate the Arp2/3 complex through the actin-binding 
protein (ABP) cortactin, which plays an important role in dendritic spine formation188.  
We thus hypothesized that Arg is mechanistically involved in regulating actin dynamics 
downstream of optoEphB2 in neurons.  To test this hypothesis, DIV11-12 neurons were 
co-transfected with Arg-YFP and optoEphB2-mCherry and photostimulated as described 
for filopodia formation.  After photoactivation, optoEphB2 and Arg signals co-localized 
in the ROI, suggesting an interaction (Fig. 3.6a).  Co-expression of kinase-dead Arg, but 
not kinase-dead Src, with optoEphB2 reduced the area explored by filopodia following 
stimulation (Fig. 3.6b).  Kinase-dead Src overexpression aids in controlling for non-
specific SH2 binding, since the Arg and Src SH2 domains are known to bind the 
juxtamembrane tyrosines of EphB250,104,177.  Additionally, treatment of neurons with the 
allosteric Arg inhibitor GNF-2 reduced the area explored by filopodia (Fig. 3.6c).  We 
thus conclude that Arg is functionally linked to EphB2 in regulating actin dynamics in 
dendrites.      
 
Discussion 
A key advantage to using an optogenetic method of receptor stimulation is tight 
spatial and temporal control over signaling.  We took advantage of this property to 
directly interrogate the effects of local EphB2 signaling in dendritic filopodia, thereby 
simulating the scenario of local contact formation with axons.  Results from prior studies 
that addressed this question were inconclusive.  Cortical neurons from EphB1-B3 triple 
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knockout mice did not show any defect in the density of dendritic filopodia16, conflicting 
with reports of increased dendritic protrusion density following ephrinB1-Fc treatment of 
cultured hippocampal neurons15.  Triple-knockout neurons also displayed impaired 
filopodial motility16, but this does not address the question of the effect of ligand-
mediated stimulation on filopodia motility.   
Our optogenetic technique expanded on prior work by allowing real-time 
observation of protrusion morphology with simultaneous stimulation of EphBs targeted 
to dendritic filopodia. We observed minutes-timescale increased actin polymerization in 
filopodia, ultimately resulting in branching and plasma membrane expansion.  Given that 
filopodia and spines are supported by a dense actin network141, such expansion of the 
membrane would suggest direct nucleation of dendritic actin networks by EphB signaling 
in filopodia.  In fact, this model is more consistent with studies that suggested Rac1 
activation and a Cdc42-N-WASP-Arp2/3 signaling complex downstream of EphB2 in 
dendrites15,147,148,150.  Dendritic spine heads contain dendritic actin networks, and as such, 
our findings may link EphB signaling to initiating spine head formation.  Further detailed 
studies of actin in filopodia and spine head markers would be necessary to draw these 
conclusions. 
Focal stimulation of EphB signaling along the dendritic shaft caused local 
formation of numerous filopodia-like protrusions.  Previous reports suggested that EphB 
signaling increased dendritic spine and overall protrusion density15, but did not 
specifically address the formation of dendritic filopodia.  Our findings would thus 
suggest that EphB signaling may increase dendritic spine density by not only converting 
filopodia to spines, but also by generating new filopodia near sites of axo-dendritic 
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contact to serve as a “positive feedback” mechanism to form more spines.  Given that 
filopodia formation was confined to areas of optoEphB2 clustering, it is possible that 
EphBs “hone” filopodia formation to sites of axo-dendritic contact.   
Interestingly, the formation of filopodial protrusions was blocked by Arp2/3 
inhibition, suggesting a role for dendritic actin nucleation.  While dendritic filopodia are 
unique in containing some actin branching, they still predominantly contain linear actin 
networks, except for the triangular filopodia base141.  Our data showed accumulation of 
F-actin predominantly at the periphery of the dendritic shaft, suggesting that EphB 
signaling may promote the formation of branched actin patches to serve as new sites for 
filopodia formation.  Additionally, neurons from EphB1-B3 triple-knockout mice, while 
failing to form spines in culture, formed F-actin patches on dendritic shafts, suggesting a 
shift in axo-dendritic contact sites from protrusions to the dendritic shafts14.  Since 
EphB2 is highly expressed along hippocampal dendritic shafts18, promoting actin 
polymerization on the shaft likely has some functional role in dendrite or dendritic spine 
morphogenesis.  EphB signaling may ensure that, even at axo-dendritic contacts along the 
dendritic shaft, proper spine formation ensues.  This result may also suggest that the 
branching and plasma membrane expansion induced in dendritic filopodia also occur 
secondary to Arp2/3 complex activation.  This provides more evidence for the nucleation 
of dendritic actin networks in filopodia.  
One recent study of EphB signaling in neurons showed reduced Tau 
phosphorylation, and subsequent mitigation of Alzheimer’s Disease progression, by 
EphB2-mediated PI3K signaling101.  PI3K activation by EphBs was also implicated in 
activation of peripheral and central pain pathways99,100.  Thus, activation of PI3K by 
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EphBs in neurons is known, and our results provide the first evidence that connects PI3K 
signaling to the actin cytoskeleton in dendrites and dendritic protrusions downstream of 
EphB2.  Given the known roles of EphBs12 and PI3K189–191 , independently, in promoting 
dendritic spine morphogenesis, these results are not surprising.  PI3K is also known to 
increase the motility of dendritic filopodia downstream of RTKs, such as Trk receptors, 
that are activated by neurotrophins192.   
Our observations of PI3K activation may be relevant in light of Rho GTPase 
regulation by EphBs in neurons.  We recently demonstrated that sub-cellular PI3K 
signaling had a strong impact on polarization of Rac1 activity in migrating cells174.  EphB 
signaling is also known to activate Rac1, and other Rho GTPases, in hippocampal 
dendrites12.  Therefore, it is plausible that PI3K activation may contribute to Rac1 
activation observed downstream of EphB signaling.  Perhaps, local accumulation of PIP3 
serves to spatially coordinate Rac1 activity at sites of axo-dendritic contact.  This may 
occur through the recruitment of GEFs.  The pleckstrin homology domains of Tiam1193    
and intersectin194, and the sec14 domain of kalirin-7195,196, have all been shown to interact 
with PIP3.   
Effects of Eph receptor signaling on the actin cytoskeleton are highly context-
dependent.  Initially, Eph receptors were thought to primarily mediate repulsive cues, 
which are correlated with the inhibition of actin polymerization10,98.  But later evidence, 
particularly in cancer and dendritic spine morphogenesis, indicated that Eph receptors 
mediate a much broader array of cell behaviors.  This included promoting cell-cell or 
cell-matrix adhesion and cell migration24.  The underlying mechanisms of this cell 
context-dependence remain poorly understood.  Our observations suggest that differential 
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regulation of PI3K, or plasma membrane PIP3 content, contributes to this phenomenon.  
Our observations and prior studies98 of EphB2 signaling suggest down-regulation of 
plasma membrane PIP3 content in conjunction with retraction of cell protrusions.  When 
we observed a protrusive phenotype in hippocampal dendrites, local accumulation of PIP3 
was observed.  Activation of PI3K was found necessary for this accumulation and 
formation of filopodia-like structures.  
Further studies are necessary to determine the underlying mechanisms of such 
differential regulation.  Differences in protein expression and effector binding between 
cell types, or between axons and dendrites, are likely involved.  This mechanism was 
suggested in a study of differential Ras/MAPK regulation by EphB4.  In human umbilical 
vein endothelial cells, EphB4 inhibited the Ras/MAPK pathway through p120RasGAP.  
In MCF7 breast cancer cells, EphB4 promoted Ras/MAPK signaling in a PP2A-
dependent manner, and p120RasGAP was not expressed79.  Since multiple Ras isoforms 
are involved in the regulation of PI3K36, it is possible that differential regulation of Ras 
also underlies our observed context-dependent effects on PIP3 synthesis.  Down-
regulation of Ras by EphB signaling is well-documented in conjunction with 
p120RasGAP72.  Numerous potential pathways exist for EphBs to activate PI3K.  In 
dendrites, a signaling complex of EphB, Src, focal adhesion kinase, and Grb2 formed 
following ephrinB ligand treatment17.  In another context, EphB1 was shown to activate 
Ras through the Ras-GEF SOS by recruiting the adaptor Grb2 through Shc76.  Thus, SOS 
may be responsible for Ras activation and downstream PI3K signaling.  GAB1 is another 
potential binding partner of Grb2 that is known to activate PI3K197.  EphB2 was shown to 
interact with the SH2 domain of a p85 regulatory subunit of PI3K in vitro, which would 
  115 
result in PI3K activation36,50.  Differences in kinase-dependent and –independent 
signaling may also account for the discrepancies.  An in vivo study of EphB signaling in 
intestinal crypts showed kinase-independent activation of PI3K to promote cell 
migration102, though a mechanism was not shown. Overexpression of kinase-dead EphB2 
has been reported to impair spine development13,14, supporting a role for a kinase-
dependent mechanism and, perhaps, differential regulation of kinase-dependent 
downstream effectors in different systems.   
Our results demonstrated a role for the non-receptor tyrosine kinase Arg in EphB-
mediated protrusion formation.  This interaction between EphB2 and Arg in neurons is 
not unexpected, as EphB2 and Arg have been shown to interact in a positive-feedback 
mechanism, and Arg is enriched in dendritic spines103,104.  However, EphB2, especially in 
the DIV10-11 age of neurons studied, has been primarily shown to drive the formation of 
dendritic spines16.  Arg, however, has been shown to promote dendrite and dendritic 
spine stability and maturation, since dendritic spines develop normally in Arg-knockout 
mice until adulthood198,199.  While EphBs likely play a role in spine stability as well, no 
studies have linked them to Arg in spine stability, let alone in spine formation.  It should 
be noted that the SH2 domains of Abl and Arg are similar and that GNF-2 allosterically 
inhibits both.  Our results may thus suggest a novel role for Arg, or Abl-family kinases in 
general, in the regulation of dendritic spine morphogenesis by EphBs.   
 The findings in this chapter thus suggested a new model by which EphBs may 
promote the formation of dendritic spines.  Instead of simply supporting a transition from 
filopodia to spines, EphBs may play a role in the formation of new dendritic filopodia 
that can form additional contacts with axons.  Our findings of differential PIP3 synthesis 
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in protrusive versus repulsive responses should prompt future work on the underlying 
mechanism.  Our findings have, thus, further elucidated important biological questions 
about the nature of EphB signaling in multiple cell types, and raised some interesting 
questions for future studies.      
  117 
Figures 
Figure 3.1 
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
5 μm
a
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
0:00 1:00 2:00 3:00 4:00 5:00 6:00
7:00 8:00 9:00 10:00 11:00 12:00 13:00 14:00 15:00
-2:00 -1:00
O
p
to
E
p
h
B
2
K
D
-O
p
to
E
p
h
B
2
f
*
A
v
g
. 
N
o
rm
. 
L
if
e
a
c
t
S
ig
n
a
l 
in
 F
il
o
p
o
d
ia
d
0:00 1:00 2:00 3:00 4:00 5:00 6:00
7:00 8:00 9:00 10:00 11:00 12:00 13:00 14:00 15:00
-2:00 -1:00
b
Opto-
EphB2
KD-Opto-
EphB2
0:00
10:00
0:00
10:00
B
lu
e
 
L
ig
h
t
-
+
0
5
10
15
20
25
30
35
40
45
%
 F
il
o
p
o
d
ia
w
it
h
 I
n
c
re
a
s
e
d
 B
ra
n
c
h
in
g
O
p
to
E
p
h
B
2
K
D
-O
p
to
E
p
h
B
2
0:00 1:00 2:00 3:00 4:00 5:00 6:00 7:00
8:00 9:00 10:00 11:00 12:00 13:00 14:00 15:00
e 5 μm
0:00 1:00 2:00 3:00 4:00 5:00 6:00 7:00
8:00 9:00 10:00 11:00 12:00 13:00 14:00 15:00
M
e
a
n
 N
o
rm
. 
P
ro
tr
u
s
io
n
 D
e
n
s
it
y
c
N.S.
  118 
Figure 3.1. OptoEphB2 activation in dendritic filopodia causes filopodia branching 
and plasma membrane expansion. DIV8-11 neurons co-expressed optoEphB2 or KD-
optoEphB2 and either myr-mCherry or Lifeact-mCherry.  Blue light (50-ms pulses, 6 
pulses/min) was delivered to specifically stimulate filopodia.  (a) Top: Illustration 
showing orientation of blue light illumination to stimulate filopodia.  Bottom: 
Fluorescence images of optoEphB2 and KD-optoEphB2, showing clustering in filopodia.  
Scale bar, 5 m.  (b) Percentage of filopodia that showed increased branching or showed 
plasma membrane expansion in response to photoactivation. n = 154 filopodia from 11 
cells for optoEphB2, n = 191 filopodia from 7 cells for KD-optoEphB2.  (c) 
Quantification of protrusion density in response to photoactivation of optoEphB2 or KD-
optoEphB2.  For each neuron, protrusion density along the ROI was measured at the start 
and end of blue light illumination.  The end value was normalized to the start value, and 
the numbers shown represent the average of all cells. Error bars, SEM.  N.S., no 
significance (t-test).  (d) Quantification of Lifeact intensity in filopodia.  Normalized 
intensity was calculated cell-by-cell by averaging the intensity in all filopodia along the 
ROIs before and after illumination, normalizing to the pre-illumination value, and 
averaging between cells.  Error bars, SEM. *p < 0.05, t-test.  (e) Time lapse images of the 
myr-mCherry signal in photostimulated filopodia. (f) Time lapse images of Lifeact-
mCherry in filopodia during photoactivation.  Time labels in (e) and (f) are relative to the 
start of photoactivation.    
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Figure 3.2 
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Figure 3.2.  Local optoEphB2 clustering induces dynamic filopodia-like protrusions 
on dendrites of hippocampal neurons in a manner that depends on Arp2/3 activity. 
(a) Left: Time lapse images of mCherry (volume marker) in DIV10-11 neurons during 
blue light illumination (50-ms pulses, 3 pulses/min.) of the indicated optoEphB2 
construct over the ROI shown (white circles).  Right: Fluorescence images of optoEphB2, 
or mutant, before and after photoactivation.   Time labels are relative to the start of 
photoactivation. (b) Time lapse images of Lifeact-mCherry in a DIV11 neuron co-
expressing optoEphB2 that was photoactivated over the ROI (white circle).  (c) 
Maximum intensity projection images of mCherry (volume marker), from the dendritic 
segments shown in (a) that express optoEphB2 and KD-optoEphB2.  Projection images 
were constructed from 5-minute time segments before and during photoactivation.   (d) 
Quantification of increased filopodial protrusions.  Dendritic areas within the ROI were 
measured from maximum intensity projections (c) and normalized to measurements 
before photoactivation.  *p < 0.05, t-test, comparing optoEphB2 to KD-optoEphB2.  (e)  
Maximum intensity projection images of mCherry (volume marker) in DIV11 neurons 
co-expressing optoEphB2.  OptoEphB2 was photoactivated (Stimulation 1) over the 
indicated ROI (white).  After 20 minutes of incubation in the dark, photoactivation was 
repeated (Stimulation 2).  Protrusive activity was reduced to baseline then re-stimulated 
to a level similar to the first photoactivation. (f) Neurons co-expressing mCherry and 
optoEphB2 were pre-treated for 30 minutes with DMSO or 200 μM CK-666 (n=16 for 
each).  The image panels show maximum intensity projections of the mCherry signal 
over the indicated timeframes.  The Kolmogorov-Smirnov plot shows the cumulative 
probability of the normalized maximum intensity projection areas within the ROI.  This 
was calculated by normalizing the value calculated from the final 5 minutes of 
photostimulation to that of the 5 minutes preceding photostimulation.  Scale bars, (a)-(c), 
(e), (f), 5 μm.    
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Figure 3.3 
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Figure 3.3. Optogenetic stimulation of optoEphB1, optoEphB6, and optoEphB2-
PBM.  Time lapse fluorescence images of optoEphB1, optoEphB6, or optoEphB2-PBM 
in DIV11 neurons. OptoEphB1 and optoEphB6 were imaged and stimulated over the 
indicated ROI (blue circles) as previously described for optoEphB2 (see Methods).  
OptoEphB2-PBM was imaged at 6 frames/min and photoactivated (440-nm light, 
between frames) over an ROI (blue circle) ~8 m in diameter.  OptoEphB1 and 
optoEphB2-PBM stimulation resulted in formation of protrusions, while stimulation of 
optoEphB6 did not.  Time labels are relative to start of photoactivation.  Scale bar, 5 m.    
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Figure 3.4 
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Figure 3.4.  Differential regulation of PIP3 synthesis downstream of EphB2 in 
dendrites and fibroblasts.  (a) TIRF images of PHAkt-mRFP (PIP3 probe) in a 3T3 cell 
co-expressing optoEphB2 and stimulated with blue light (442 nm laser). (b) Intensity 
linescan of PHAkt signal near the cell leading edge as indicated by the dashed line in (a). 
Each line (from the darkest to the lightest) indicates a different time point with 30 sec 
spacing. (c) Quantification of PHAkt sensor intensity at the leading edge (1 m from cell 
edge).  Time points represent 1 minute before (Before), the start of (- Blue Light), and 
after 1 min. of (+ Blue Light) blue light stimulation (n=6).  *p < 0.05, t-test, comparing to 
“Before.” (d) Quantification of PHAkt intensity at the cell interior (5 m from cell edge), 
using the same time points as in (c)  . (e) Time-lapse images of PHAkt-mRFP or mCh in 
dendrites of DIV10-11 neurons during photoactivation (ROI, white circles) of optoEphB2 
and filopodia formation. (f)  Quantification of PHAkt or mCherry accumulation within the 
ROI upon optoEphB2 activation and filopodia formation in neurons. Values represent 
mean fluorescence intensity within the ROI normalized to the mean prior to 
photoactivation and averaged between cells.  Error bars, SEM.  (g)  Maximum intensity 
projections of PHAkt-mRFP in dendrites before and after optoEphB2 photoactivation over 
the ROI (white circles). Scale bars, (a), (e), (g), 5 µm. 
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Figure 3.5 
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Figure 3.5.  OptoEphB2 activates PI3K in dendrites to induce PIP3 accumulation.  
(a) Left: Fluorescence images of PHAkt-mRFP dendrites before and after two rounds 
optoEphB2 stimulation (ROI, white). The top row shows the first stimulation.  The 
neurons were then incubated in the dark and treated with the PI3K inhibitor LY294002.  
Re-stimulation is shown in the bottom row. Right: Quantification of PHAkt-mRFP 
intensity in the ROI, normalized to the mean signal prior to blue light illumination.  Error 
bars, SEM (n=3). (b) Same as in (a) except, that neurons were treated with DMSO 
(control) instead of LY294002. Error bars, SEM (n=3).  (c) Maximum intensity projection 
images of PHAkt-mRFP in a dendritic segment.  OptoEphB2 was photoactivated (white 
circle; ~8 μm, 50-ms pulses, 10-s intervals), incubated in the dark, and re-illuminated 
following treatment with 5 µM Cytochalasin D, similar to (a) and (b). Plot on the right 
shows PHAkt-mRFP signal normalized to the mean prior to illumination for both 
stimulations.  Scale bars, (a)-(c) 5 µm.  All time labels are relative to the start of 
photoactivation.      
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Figure 3.6 
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Figure 3.6. OptoEphB2 promotes dendritic filopodia formation by signaling through 
the non-receptor tyrosine kinase Arg.  (a) Time lapse images of DIV10-11 
hippocampal neurons co-expressing ArgKD-YFP and OptoEphB2, before and after blue 
light illumination (white circle; 50-ms pulses at 20-s intervals). (b) Maximum intensity 
projections of optoEphB2 signal in DIV10-11 neurons co-expressing ArgKD-YFP, 
SrcKD-YFP, or YFP, over the indicated time frames.  Plot at right shows normalized 
maximum projection area, calculated by dividing the area over the final 5 minutes of 
photoactivation by that of the 5 minutes preceding photoactivation. Error bars, SEM. 
*p<0.01, t-test. (c) DIV11-12 neurons co-expressing optoEphB2 and mCherry were 
photostimulated after incubation with DMSO or 10 μM GNF-2 for 1 hour.  GNF-2 
treatment reduced the average normalized maximum intensity projection area, measured 
during the final 5 minutes of photoactivation.  Error bars, SEM. *p<0.01, t-test.  (d) 
Maximum intensity projections of mCherry signal in DIV11-12 neurons, co-expressing 
optoEphB2, that were pre-treated with DMSO or GNF2 as in (c).  Photoactivation was 
delivered over the ROI shown (white).  Scale bars, (a), (b), (d), 5 μm.  
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Movie Captions 
 
Movie 3.1. OptoEphB2 activation causes filopodia branching and F-actin 
accumulation. Lifeact-mCherry signal in filopodia from DIV9 neurons co-transfected 
with optoEphB2 (Left) or KD-optoEphB2 (Right).  Branching and Lifeact accumulation 
occur with focal blue light illumination (blue dot) of optoEphB2. 
 
Movie 3.2.  OptoEphB2 activation in filopodia forms lamellipodia-like protrusions. 
Movie of myr-mCherry signal in DIV9 neurons, co-expressing optoEphB2, that shows 
formation of lamellipodia-like protrusions from filopodia following localized optoEphB2 
stimulation (starts at 0:00).  
 
Movie 3.3. Local stimulation of optoEphB2 in dendrites induces formation of 
filopodia-like protrusions.  Movie of mCherry signal in DIV11 neurons co-expressing 
optoEphB2 (Left) or KD-optoEphB2 (Right).  Following focal (blue circle at 5:00) blue 
light illumination (blue dot) of optoEphB2, numerous filopodia-like protrusions form.  
 
Movie 3.4.  Filopodial protrusions are associated with PI3K activation and PIP3 
accumulation.  Movie of PHAkt-mRFP signal in DIV11 neurons co-expressing 
optoEphB2.  Blue light illumination (blue dot) of optoEphB2 caused accumulation of 
PHAkt (Left) in the ROI (blue circle at 5:00).  After incubating in the dark and treating 
with 50 M of the PI3K inhibitor LY294002, neurons were re-stimulated (Right) and 
both PHAkt accumulation and protrusion formation were abrogated.    
 
Movie 3.5. Formation of filopodial protrusions is reversible and repeatable. Movie of 
PHAkt-mRFP signal in DIV11 neurons co-expressing optoEphB2.  PHAkt-mRFP 
accumulation in the ROI (blue circle at 5:00) was observed (Left) with dendritic 
protrusion formation in response to focal optoEphB2 photoactivation (blue dot).  Both 
accumulation and protrusion formation were repeatable upon re-stimulation after 30 
minutes of DMSO treatment (Right). 
 
Movie 3.6.  PIP3 accumulation occurs in the absence of actin polymerization. PHAkt-
mRFP accumulation in the ROI (blue circle at 0:00, then at 5:00 following cytochalasin 
D treatment) was observed with dendritic protrusion formation in response to focal 
optoEphB2 photoactivation (blue dot).  During re-stimulation, treatment with 5 µM 
cytochalasin D blocked protrusion formation, but did not prevent repeated accumulation 
of PHAkt-mRFP.  
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CHAPTER IV: Discussion and Future Directions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Attribution:  This chapter was proof-read by Ji Yu and Yi Wu.  Clifford Locke wrote the 
text.   
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Summary 
In neurons, EphB signaling was originally studied in the context of axon 
guidance62.  It was found that EphBs, among other Eph receptors, acted as repulsive cues, 
and Eph/ephrin expression gradients targeted axons to their appropriate destinations64.  A 
role for EphBs in dendritic spine formation was first described when overexpression of 
kinase-dead EphB2 caused impaired dendritic spine formation in cultured hippocampal 
neurons13.  Genetic studies would later reveal that EphB1, EphB2, and EphB3 are 
collectively essential for the normal formation of dendritic spines14.  Additionally, 
stimulation of cultured neurons with pre-clustered ephrinB ligands induced dendritic 
spine formation and spine head enlargement15.  
Dendritic filopodia are thought to give rise to dendritic spines by forming stable 
contacts with axons, and subsequent reorganization of the actin cytoskeleton4,200.  To 
better understand the role of EphBs in this process, previous studies addressed the effect 
of EphB signaling on the motility and morphology of dendritic filopodia.  Cultured 
neurons from EphB1-B3 triple knockout (TKO) neurons showed reduced filopodia 
motility versus wild-type neurons16, though this did not address the effect of ligand 
binding.  Filopodia density was unaffected in these neurons16, contrasting with another 
study that reported increased total protrusion density following stimulation of cultured 
hippocampal neurons with pre-clustered ephrinB ligands15.  These results were, therefore, 
inconclusive regarding the effects of EphB signaling on filopodia at sites of axo-dendritic 
contact.  
I became interested in the effect of EphB signaling on the morphology and 
motility of dendritic filopodia to better understand how EphBs affect the actin 
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cytoskeleton to induce spine morphogenesis. Given the role of clustering in EphB 
signaling, and the recent report of blue light-induced clustering of Cry2129, I decided to 
use an optogenetic approach to model local axo-dendritic contacts and target stimulation 
to filopodia. Concurrent development of other blue light-controlled RTKs132,133 supported 
this idea.  Such a technique would allow real-time monitoring of filopodia motility, 
morphology, and downstream signaling proteins following local EphB2 stimulation.   
Chapter II reported the development of optoEphB2 for optogenetic control over 
EphB2 signaling. Blue light illumination of optoEphB2 resulted in rapid tyrosine 
phosphorylation and binding of SH2 domains to phosphotyrosine residues in cell lysates.  
The corresponding SH2 domain proteins mirrored those known to act downstream of 
EphB2.  Expected cell-cell retraction phenotypes were demonstrated in MEF, HEK293, 
and MCF7 cells and axonal growth cones.  Spatio-temporal control over optoEphB2 was 
confirmed by showing reversibility and repeatability of clustering and signaling, and 
confinement of both clustering and expected phenotypes to sub-cellular regions of 
illumination.   
Chapter III focused on the effect of EphB signaling on actin in dendritic filopodia 
and along the dendritic shafts.  With targeted optoEphB2 clustering, filopodia displayed 
increased actin polymerization and branching, some to the extent of showing plasma 
membrane expansion, indicative of a highly-branched, or dendritic, actin network. On the 
dendritic shaft, optoEphB2 clustering promoted the formation of filopodia-like structures, 
which depended on the accumulation of phosphatidylinositol(3,4,5)-triphosphate (PIP3) 
downstream of phosphoinositide-3 kinase (PI3K).  Given the reduction of plasma 
membrane PIP3 associated with EphB2-mediated cell collapse, differential regulation of 
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plasma membrane PIP3 could represent a mechanism for the cell context-dependence of 
Eph receptor signaling.  
This thesis reports the successful development of a photoactivatable Eph receptor 
that may be used in a variety of contexts.  Activation of optoEphB2 in dendritic 
protrusions and along dendritic shafts improved our understanding of EphB signaling in 
the development of dendritic spines.  A greater mechanistic understanding of the 
differences between EphB signaling in dendrites and other cell types was also achieved.  
My final comments on this thesis are given in this chapter.      
 
Discussion and Future Directions 
 
Development of an optogenetic method for Eph receptor activation 
 A primary goal of this thesis was to target EphB signaling to dendritic filopodia.  
Optogenetic clustering using Cry2 was an intriguing method, and our design was 
achieved after multiple iterations.  After just one minute of blue light illumination, we 
achieved robust tyrosine phosphorylation and binding of multiple SH2 domains.  
Collapse of MEFs, localized cell process retraction, and growth cone collapse were 
observed with patterned blue light illumination of transfected cells, in agreement with 
previously observed phenotypes of EphB2 signaling.  Our data suggest that we have a 
functional optogenetic module for spatial and temporal control over Eph receptor 
signaling.    
 Using an optogenetic tool for Eph receptor signaling will permit assays for the 
spatial and temporal regulation of downstream signals.  This is especially important for 
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the Rho and Ras GTPases, which are important downstream effectors of Eph receptors. 
Their complex interplay in space and time is responsible for proper cell migration.  
Changes in Rho GTPase activity occur on the timescale of minutes, and their activities 
are confined to sub-cellular regions.  Numerous probes have been developed to examine 
the spatial and temporal characteristics of Rho GTPases in a variety of processes, for 
instance, the formation of cellular protrusions201.  The next logical step is to examine how 
the spatial and temporal characteristics of upstream regulators, such as the Eph receptors, 
can affect these signaling patterns.  
An optogenetic tool also opens the door for in vivo work.  Many studies of Eph 
receptors in vivo employed knockout models.  While these studies are informative, Eph 
receptors are RTKs that affect Ras/MAPK signaling and, therefore, expression of genes 
involved in cell survival, proliferation, and differentiation.  These effects may confound 
experimental observations.  Since Ephs and ephrins are so widely expressed and are 
involved in crucial developmental processes, knockouts are often lethal.  For instance, it 
was reported that vascular problems in EphB2/B3 double-knockout mice caused a 30% 
lethality rate69.  Using an optogenetic tool permits targeted signal activation and, thus, 
stimulation of a particular organ to achieve spatial specificity.   
 
Novel insights into dendritic spine morphogenesis 
 Induction of actin branching suggests that EphB2 signaling can contribute to 
spine head formation on filopodia, though new spines were not observed, possibly due to 
the loss of extracellular domain-mediated interactions or the absence of a pre-synaptic 
membrane that may contribute trans-cellular co-stimulatory signals that are also 
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necessary for dendritic spine development.  Prior data indicated the necessity of EphB 
signaling in the development of dendritic spines14. We thus speculate that EphB2 activity 
is necessary, but not sufficient, for the development of dendritic spines.  Prior studies 
showed increased spine density via treatment with pre-clustered ephrinB ligands15, 
suggesting that EphB stimulation was sufficient for additional spine formation.  
However, these spines may have formed at contacts with axons, a notion supported by 
immunofluorescence assays that showed an increased density of co-localizing puncta 
containing pre- and post-synaptic markers15.  If these spines formed at axonal contacts, it 
is likely that other cell-cell recognition molecules, and perhaps glutamatergic activity, 
supplemented EphB signaling to complete spine formation.  The ability of EphA4, which 
is enriched at dendritic spines202, to bind ephrinBs23 also sheds doubt on the sufficiency 
of EphB signaling alone to induce spines.  
 Since axons and dendrites can form local contacts on dendritic shafts, we 
examined the effect of local EphB signaling on dendritic shafts as well and observed 
formation of new filopodia-like protrusions.  An early study of EphB signaling in 
dendritic spine morphogenesis described an increase in total protrusion density following 
ephrinB1-Fc ligand treatment of cultured hippocampal neurons15.  It was, however, 
unclear if EphB signaling induced the formation of new protrusions or served to stabilize 
extant filopodia and spines.  The latter case would strongly suggest a function for EphB 
signaling in stabilizing filopodia upon contact with axons, a crucial initial step in 
dendritic spine morphogenesis9.  Our observations show spatially-restricted formation of 
filopodia-like protrusions, suggesting that EphB signaling up-regulates spine density by 
introducing additional putative synapses.  Spatial restriction suggests that EphB signaling 
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at axo-dendritic contacts may help neurons “hone” filopodia formation to dendritic 
locations nearest axons.  Future experiments may explore how spatial confinement of 
filopodia formation is achieved.   
The design of optoEphB2 may also explain the discrepancy between our 
stimulation protocol and results of ligand-mediated stimulation.  Removal of the 
extracellular domain was advantageous to reduce interactions with endogenous ephrins 
and cis interactions with other receptors, but EphB2 was shown to interact with 
NMDARs via its extracellular domain20.  The Cry2olig-mCherry fusion at the receptor’s 
C-terminus blocked the carboxy terminus of the PDZ-binding motif, which was shown to 
scaffold EphB2 together with AMPARs through GRIP156.  Structural studies have 
suggested that a free carboxy-terminus is necessary for PDZ binding, but this conclusion 
is controversial186,203.  Our data indicated that placing the PBM at the C-terminus of 
optoEphB2 did not have a significant impact on filopodia formation in dendrites.  Given 
that isolated PBMs were shown to bind PDZ domains186, we suspect that moving the 
PBM itself to the C-terminus of optoEphB2 would allow interactions with PDZ domains.  
A C-terminal YFP fusion of EphB2 did not affect the normal kinase activity or regulation 
of EphB2, and stimulation of NG108 cells overexpressing EphB2-GFP fusion caused the 
expected retraction of neurites182.  Additionally, overexpression of an EphB2-YFP fusion, 
in which YFP was inserted N-terminal to the EphB2 PBM, rescued dendritic spine 
morphogenesis in EphB1-B3 TKO neurons16,156.  This is similar to the design of 
optoEphB2-PBM. I thus suspect that the placement of the PBM in optoEphB2 did not 
significantly affect the validity of the experimental results, or the conclusions drawn from 
them.  However, these results can only be interpreted as showing the effects of EphB 
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kinase activity on dendritic filopodia.  Since previously-demonstrated interactions with 
GEFs did not involve the PBM15,147,150, EphB kinase activity is likely the driving force in 
spine morphogenesis and these caveats do not detract from the significance of the 
findings. 
Future studies may focus on how EphB2 recruits various synaptic proteins to 
filopodia to affect the actin cytoskeleton.  For example, the Shank family of scaffolding 
proteins, which are enriched in spines, contain SAMs6 that may bind the SAM of EphB 
receptors to affect filopodia.  Using the optogenetic tool to map the temporal 
characteristics of actin and effector recruitment may permit differentiation between 
effectors that are recruited to affect the actin cytoskeleton, and which effectors may then 
be recruited by actin polymerization per se.  Spatial restriction may also permit 
observation of differences between effects at filopodia, and effects on the dendritic shaft.  
An increase in filopodia density was not observed with stimulation of filopodia 
specifically, indicating that downstream signals were confined to filopodia, or that there 
were differences in the signaling pathways initiated between the dendritic shafts and 
filopodia.  Studies on individual spines may also be performed to examine the effect of 
Eph receptor signaling on dendritic spine plasticity.     
 
Implications for understanding the cell context-dependence of EphB2 signaling 
 This thesis reports the first direct evidence of PI3K activation by EphB2 in 
dendrites.  EphB signaling was previously shown to affect pain pathways and 
Alzheimer’s Disease pathogenesis through PI3K99–101, though the localization of PI3K 
activation remained unknown.  Our observation of PI3K signaling by EphB2 in dendrites 
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builds on the well-studied regulation of the Rho GTPases by EphB2 and the role of PI3K 
in mediating Rho GTPase signaling.  Our lab recently published a paper showing the 
spatial regulation of Rac1 through PI3K activity174.  Prior studies have shown that PIP3 
can interact with the PH domains of the EphB2-interacting GEFs intersectin194 and 
Tiam1193 and the sec14 domain of kalirin-7195,196.  Thus, it is possible that EphB2-
mediated PIP3 synthesis may serve to spatially coordinate Rac1 and Cdc42 activation 
near sites of axo-dendritic contact to drive dendritic spine morphogenesis, and future 
experiments should address this question.  Additionally, PIP3 synthesis was well-
localized to the region of illumination, especially considering the rapid diffusion of 
membrane lipids.  The mechanism of such spatial restriction should be explored.  Local 
accumulation of PIP3 itself may be promoted, for instance, by the surrounding actin 
dynamics, as demonstrated in chemotaxis187, or perhaps by rapid PIP3 dephosphorylation 
or internalization.  Use of an optogenetic tool, including EphB2, would be crucial to such 
studies for spatial regulation of upstream signals.  Such work could be extended to spatial 
regulation in migratory cells to study, for example, how actin is spatially regulated to 
achieve contact inhibition of locomotion.    
 Our results in MEFs and growth cones contradicted our observations of increased 
protrusive activity and PI3K activation in dendrites.  Observations of cell protrusion 
collapse and changing growth cone morphology from lamellipodial to filopodial strongly 
suggest collapse of dendritic actin networks.  However, broad plasma membrane 
extensions were induced in filopodia, suggesting nucleation of dendritic actin networks.  
In the case of hippocampal neurons, these diametrically opposed phenotypes were found 
in the same cell type. Observing PIP3 accumulation in dendrites, with depletion in 
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collapsing MEFs, suggests that Eph receptor-induced repulsion or adhesion depends, at 
least in part, on up- or down-regulation of plasma membrane PIP3.     
Further studies are therefore necessary to elucidate the neuronal pathways 
between EphB2 and PI3K that result in activation or inhibition.  Prior in vitro studies 
indicated an interaction between phosphorylated EphB2 and the SH2 domain of p85 ( or 
 not specified)50, which would result in PI3K activation. EphB2 may signal through Ras 
in a cell context-dependent manner to activate or inhibit PI3K36.  EphB2 is known to 
inhibit Ras signaling through p120RasGAP in multiple contexts, though the SH2 adaptor 
Grb2 was recruited to EphB signaling complexes in hippocampal dendrites17,72.  Grb2 
may activate PI3K through Ras by recruiting the Ras-GEF SOS, as shown in other cell 
types downstream of EphB176.  Grb2 may act independently of Ras by recruiting another 
adaptor, Gab1, that can activate PI3K197.  Our SH2 domain profiling, however, did not 
detect binding of the SH2 domains of Grb2, p85α, p85β, or p55γ to phosphotyrosines 
downstream of optoEphB2 (Fig. 2.3c).  These SH2 domains did bind the positive controls 
(Fig. 2.3c).  Activation of PI3K via these pathways is, therefore, less likely.  EphB2 was 
also shown to form a complex with the Rac-GEF -Pix, Nck, and Pak, with PI3K activity 
necessary to activate -Pix96.  Although Nck did bind optoEphB2 in our assay, and is 
known to bind EphBs50, this does not explain the activation of PI3K.  It is also possible 
that PI3K activation occurs through activation of Rac1 or Cdc42 as previously described 
in other contexts37,174. 
In addition to understanding the pathways themselves, central to Eph biology is 
understanding the underlying mechanisms of cell context-dependence, and how that may 
affect the pathways selected in different cell types. A study of EphB4 signaling to Ras 
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supports the notion that differential expression of downstream effectors is responsible for 
cell context-dependence79.  EphB4 inhibited proliferation in human umbilical vein 
endothelial cells by down-regulating Ras through p120RasGAP, which was abrogated by 
p120RasGAP knockdown.  However, EphB4 increased cell growth in MCF7 cells by up-
regulating Ras activity in a manner that depended on the phosphatase PP2A.  Other 
studies suggest that the signaling background provided by other receptors may determine 
the Eph receptor output.  For instance, a study of cross-talk between EphB2 and FGFR 
showed that EphB2 inhibited Ras when FGFR was activated, but activated Ras when 
FGFR was not78.  Feedback control of EphBs by the MAPK cascade was described as the 
underlying mechanism.  EphB signaling inhibited chemotaxis in MTLn3 cells that 
overexpressed EGFR98, which perhaps resulted in a Ras-activating background as well.  
To determine the underlying biology in hippocampal neurons, it will be necessary 
to examine the dendritic and axonal expression of potential EphB2 downstream targets.  
Perhaps p120RasGAP is lacking in dendrites, but is expressed in axons, allowing EphBs 
to up-regulate Ras through other adaptors and activate PI3K in dendrites.  Down-
regulation of Ras in growth cones by the typical mechanisms may explain growth cone 
collapse.  Functional assays would identify proteins that may reverse the functional 
outcome of EphB2 signaling, discoveries that would mark a great advance in 
understanding Eph receptor biology.  
OptoEphB2 provides a functional module to approach these questions of cell 
context-dependence, particularly in the case of polarized cell types.  Neurons provide an 
example, because protein expression and signaling activity can differ greatly between 
axons and dendrites.  However, migrating cells may also be polarized, especially during 
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chemotaxis, with different signaling activities at the leading and lagging edges.  Our data 
and previous studies have shown that EphBs behave differently in the axonal and 
dendritic compartments of hippocampal neurons.  Activation of other RTKs, such as 
FGFR, can influence the regulation of Ras/MAPK signaling by EphBs, through feedback 
mechanisms in the Ras/MAPK pathway78.  In Dictyostelium, spatial regulation of Ras and 
PI3K signaling, with activation at the leading edge, has been demonstrated to guide 
chemotaxis204,205, providing an example of how spatial regulation of proteins at the 
cellular level affects cell migration.  This raises the question of whether or not Eph 
receptors differentially mediate adhesion or repulsion at the leading or lagging edges of 
migrating cells.   Immunofluorescence can be used to detect spatially-regulated binding 
between receptors and their effectors.  However, optogenetics can be used to monitor 
recruitment of effectors over space and time while simultaneously observing downstream 
phenotypes.  This advantage will allow future studies to probe the effects of Eph receptor 
signaling in different cell compartments, which will expand our understanding of the role 
that cell context plays in Eph receptor signaling outputs.     
 
Conclusion 
  OptoEphB2 can be used for spatial and temporal control over an RTK that is 
crucial to normal spine development and other developmental processes.  This thesis 
demonstrated the local morphologic effects of EphB2 signaling on the dendritic spine 
precursors, dendritic filopodia, and suggested an important signaling pathway in 
determining adhesion versus repulsion in response to EphB2 signaling.  These 
observations improved the scientific understanding of EphB2 signaling in spine 
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formation, and opened an array of new questions to continue exploring the molecular 
mechanisms of the cell context-dependence of Eph receptor signaling.  
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